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General introduction 11
INTRODUCTION
This prologue focuses on the fundamentals of peritoneal tumour recurrence after surgical 
resection of gastro-intestinal tumours. This will be the rationale on which the investigations 
described in this thesis are founded. For the studies outlined in this thesis only human 
derived cancer and mesothelial cells were used. 
Gastro-intestinal malignancies
The incidence of gastro-intestinal malignancies is increasing in the western world and 
accounts for more than 50% of all malignancies. Colorectal cancer is a leading cause of 
morbidity and mortality with about 400 000 new cases and 200 000 deaths in Europe 
each year.1, 2 According to an estimation of the International Agency for Research on 
Cancer, colorectal cancer was in the year 2004 the most common form of cancer di-
agnosed in the European Union, both sexes combined.1 The overall 5 year survival rate 
for colon cancer is 60-70%. For patients with local recurrence the 5 year survival rate is 
approximately 35%. For patients with distant metastasis the 5 year survival is 25%.3 
An more fatal disease is pancreatic cancer. Pancreatic ductal adenocarcinoma is a 
major cause of cancer death in the Western world and is responsible for nearly 65 000 
deaths per year in Europe.4, 5 Pancreatic cancer is a disease with a very poor prognosis 
and is often in an advanced state of disease. Less than 15% of the patients survive the 
ﬁ rst year and the 5-year survival is approximately 3%. As with colorectal cancer the most 
common site of local recurrence is the resection site. The intra-abdominal recurrence rate 
after curative resection ranges between 38% and 86%.6-9 
For both colon and pancreatic cancer the locoregional recurrence rate is high. Therefore, 
knowledge of the pathophysiology of recurrences is of the utmost importance in order to 
develop more speciﬁ c tools to attack the initial process of implantation of tumour cells in 
the peritoneal cavity.
Local tumour recurrence
Local tumour recurrence after curative surgery is a persistent problem in the treatment of 
gastro-intestinal cancer. Local recurrence is denoted as regrowth of tumour in and around 
the resection site, including the pericolic fat, the adjoining mesentery and lymph nodes, 
the peritoneum or the suture or staple line of the bowel anastomosis. 
The incidence of local recurrence following colorectal cancer varies between 3 and 
32%.10-16 Although time to recur varies, 55-80% of local recurrences occur during the 
ﬁ rst two years after curative resection.10 There are ample speculations on the evolution of 
local recurrence. The ﬁ rst and most feasible explanation, is that local recurrence may oc-
cur after resection of a locally advanced colorectal carcinoma, which already penetrates 
the peritoneal surface or adjacent organs. Local peritoneal involvement has a detrimental 
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inﬂ uence on the prognosis after planned curative resection.17, 18 Secondly, the presence 
of cancer cells in the abdominal cavity prior or during surgery has a signiﬁ cantly deterio-
rating inﬂ uence on overall survival. Recent studies revealed that 20-30% of the patients 
with colorectal cancer have a positive immunocytology of the peritoneal washings before 
handling of the tumour. According to the results of these recent investigations, peritoneal 
cytology after curative resection might serve as a prognostic tool in colorectal cancer 
management.19-23
The hypothesis extensively propagated by Sugarbaker is the tumour cell entrapment 
theory. Manipulating and removing a tumour, especially a stage III adenocarcinoma, 
will cause leakage of tumour cells out of the transected lymphatic channels into the resec-
tion site and free peritoneal cavity. Furthermore, by extensively pulling the tumour, the 
interstitial tissue close to the tumour might be traumatized and this will cause a release 
of tumour emboli from the margins of dissection. Tumour cells can also reach the free 
abdominal cavity by leakage out of the transected veins.24 The free ﬂ oating tumour cells 
will precipitate on the raw tissue surface on which ﬁ brin is released. Hereafter, inﬂ am-
matory cells will encounter the ﬁ brin deposition and participate in the healing process 
by releasing cytokines and growth factors, which is an excellent environment for tumour 
cells to ﬂ ourish.24, 25 In order to prevent tumour spill during surgical tumour resections, 
‘the no touch isolation technique’ was developed. This technique implies the vascular 
ligation before manipulation of the tumour during surgical resections.26 Although tumour 
spill might be decreased by this surgical technique, a beneﬁ t in survival has not been 
revealed.27 
Peritoneum and mesothelial cells
In 1827 Bichat observed that the surface of the serous cavities was covered by ﬂ attened 
cells. He emphasized their similarity with cells lining the lymphatics, and therefore classi-
ﬁ ed the serosal cavities as part of the lymphatic system.28 
The surfaces of the pleural, peritoneal and pericardial cavity are covered by the mesothe-
lium. The mesothelium covering the internal organs is known as visceral, while the parietal 
mesothelium surrounds the abdominal cavity. This peritoneal tissue is a monolayer and its 
epithelial characteristics are closely shared with those of the endothelium, for this reason 
mesothelium and endothelium were regarded previously as one and the same tissue.29
The peritoneal mesothelium is a highly specialized monolayer of polarized ﬂ at epithelial 
cells that covers the entire surface of the abdominal cavity. It serves as a protective ana-
tomical barrier, as a non-adhesive friction-less interface for the movement of abdominal 
organs and is involved in the formation and turnover of abdominal ﬂ uid. The integrity of 
the mesothelial cell lining is a prerequisite for these functions. Injury to the abdominal cav-
ity is a common phenomenon. It can be caused by trauma, surgery, infections, or various 
neoplasms. Both inﬂ ammatory and neoplastic processes in the abdominal cavity are as-
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sociated with marked structural alterations of peritoneal mesothelium, which include loss 
of polarization, cellular retraction with exposure of the submesothelial extracellular matrix 
(ECM), and frequently detachment and suspension of mesothelial cells in peritoneal effu-
sions.30 The precise pathological mechanisms involved in the disruption of the mesothelial 
integrity are still poorly deﬁ ned, but are likely to involve alterations of the expression of 
mesothelial adhesion molecules.31-33
The mesothelial cells were once considered to be passive cells, but there is now compel-
ling evidence, which highlights their critical role in antigen presentation, inﬂ ammation, 
wound healing, and transport of ﬂ uids and cells across the serosal cavities.34, 35
The introduction of peritoneal dialysis (PD) as a treatment therapy for patients with end-
stage renal disease provoked much interest in the biological and molecular aspects of 
the peritoneal mesothelial cell. These cells provide the ﬁ rst line of defence in peritoneal 
protection during long-term or repeated exposure to unphysiologic PD solutions, and 
against micro-organisms during infective peritonitis. Human peritoneal mesothelial cells 
can be cultured in vitro and provide means to investigate the effects of a PD solution or 
its components on cell proliferation and wound healing; synthesis of matrix proteins, cy-
tokines, and growth factors; and cell-cell, cell-matrix, and bacteria-cell interactions.36-40
Mesothelial cells play an important role in peritoneal homeostasis and contribute to ﬂ uid 
and cell transport, initiation and resolution of inﬂ ammation, tissue repair, and prevention 
of adhesion formation, and are the ﬁ rst line of defence against foreign agents. Mesothe-
lial cells are active cells that can synthesize a plethora of pro-, anti-, and immunomodu-
latory mediators that include growth factors, cytokines, hyaluronan, nitric oxide, and 
prostaglandins. These mediators are released in response to bacterial infection, chemical 
or surgical injury, with the aim of initiating the reparative processes and restoring the 
homeostasis in the peritoneum.41, 42 Phagocytosis of foreign agents by mesothelial cells 
induces secretion of chemotactic peptides, following activation with pro-inﬂ ammatory 
cytokines (IL-1β, IL-6, IL-8, TNF-α) and in that way contributes to the intraperitoneal recruit-
ment of leukocytes during peritoneal inﬂ ammation.43, 44
The establishment of a reproducible methodology for peritoneal mesothelial cell isolation 
has led to an increase in mesothelial cell research in areas that encompass wound heal-
ing, inﬂ ammation and defence of foreign material. Mesothelial cell culture also offers an 
invaluable tool to investigate the underlying mechanism of cell signalling and cell-cell 
interactions and adhesion. 
Trauma , Inflammation and Cytokines
Since Virchow’s studies in the mid nineteenth century, the role of inﬂ ammation and wound-
ing as an initiator and promoter of tumour development has been implied. Virchow 
indicated that cancers tended to occur at sites of chronic inﬂ ammation.45
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The investigation aiming to clarify the relationship between inﬂ ammation and cancers ﬁ rst 
led to the determination, whether the reactive oxygen and nitrogen species generated by 
inﬂ ammatory cells, such as leucocytes recruited to the inﬂ ammatory foci to kill infectious 
agents, may cause mutagenic assaults and result in tumour initiation.46 Nowadays, it has 
been realized that the development of cancers from inﬂ ammation might be a process 
driven by inﬂ ammatory cells and by a variety of mediators, including cytokines, chemo-
kines, and enzymes, which altogether establish an inﬂ ammatory microenvironment.47 
Inﬂ ammation is a process in response to tissue damage caused by microbial pathogen 
infection, chemical or mechanical induced wounding.48 At the very early stage of inﬂ am-
mation, neutrophils are the ﬁ rst cells to migrate to the inﬂ ammatory sites under the regula-
tion of molecules produced by rapidly responding macrophages and mast cells present 
in tissues.47, 49 As the inﬂ ammation progresses, various types of leucocytes, lymphocytes, 
and other inﬂ ammatory cells are activated and attracted to the inﬂ amed site by a signal-
ling network involving a great number of growth factors, cytokines and chemokines. 
Surgical trauma induces an acute phase response, during which tissue damage will be 
controlled, infective organisms will be killed and the repair process will be induced. The 
acute phase response is initiated by macrophages and monocytes entering the surgical 
traumatized site, which release pro-inﬂ ammatory cytokines, tumour necrosis factor alpha 
(TNF-α) and interleukin-1 beta (IL-1β).50 TNF-α and IL-1β stimulate the production and 
release of other cytokines, like interleukin 6 (IL-6).51, 52 These cytokines are potential 
modulators of the expression of cell adhesion molecules (CAMs) and regulate in that 
respect the adhesiveness between leucocytes and the endothelium.53 Parallel to the en-
dothelium, the inﬂ ammatory cascade following surgical trauma in the peritoneal cavity, 
might create an outstanding environment for residual or spilled tumour cells to adhere to 
mesothelial cells.
Adhesion Molecules
Adhesion molecules are complex membrane proteins that play important roles in the 
interaction between leukocytes and mesothelial cells in the inﬂ ammatory process. 
Adhesion molecules are divided into three major classes. Each class regulates a par-
ticular step in the adhesion cascade. Selectins constitute one class. Selectins are trans-
membrane proteins involved in the early phase of adhesion cascade. They facilitate the 
establishment of relatively weak bonds between leukocytes and endothelial cells.54
The second class of adhesion molecules are integrins. Integrins are complex transmem-
brane proteins made of 2 subunits, α and β. They are arranged in subgroups according 
to the type of subunit.55, 56 The integrins are in a nonactive form and can be stimulated by 
cytokines, where after strong bonds between cells can be assembled. 
The third class of adhesion molecules is the immunoglobulin-like superfamily, including in-
tercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-
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1). They have been detected in a variety of cell types including leukocytes, endothelial 
cells, and epithelial cells.57-59 These molecules can be co-expressed on the same cell and 
cell adhesion can be considered as their core business. ICAM-1 binds to integrin LFA-1 
(αL/β2) and VCAM-1 to VLA-4 (α4/β1, α4/β7).57, 60, 61 
A further elucidation of the mechanism by which mesothelial cells regulate their expres-
sion of adhesion molecules and receptors will help in our understanding of the invasion 
and metastasis of tumours. 
Previous Studies
The development of peritoneal tumour recurrence after surgical trauma has been studied 
extensively in our department. Eggermont et al. demonstrated the stimulating effect of 
enhanced surgical trauma on peritoneal tumour development in a murine model.62 A 
randomized clinical study of Busch et al. investigated the effect of blood transfusions 
on survival after colorectal surgery. In this study the effects of autogenic and alloge-
neic blood transfusion in patients with colorectal cancer were investigated. This trial 
concluded that the negative effect of blood transfusion and local cancer recurrence is 
indirect and probably caused by the circumstances during the surgery that necessitate 
the transfusion. 63, 64 
Van den Tol investigated initially the effect of surgical trauma on adhesion formation 
in an in vivo rat model and concluded that the extent of adhesion formation correlates 
signiﬁ cantly with the degree of peritoneal trauma.65, 66 These investigations showed a 
correlation between the amount of peritoneal trauma with the degree of tumour take.67 
Minimal invasive techniques and local recurrence were studied by Bouvy et al, and this 
experimental in vivo rat model ended up with the conclusion that laparoscopic surgery is 
associated with less tumour growth compared with conventional surgical techniques.68
In the established in vivo rat model red blood cell-derived factors did appear to prevent 
tumour cell adhesion to the peritoneum, but did not inhibit tumour growth.69 Ensuing ex-
periments done by van Rossen exhibit that the antioxidant enzymes superoxide dismutase 
(SOD) and catalase, both components of the red blood cell, are responsible for the 
inhibition of tumour adherence.70 
Following in vivo experiments, in which lavage ﬂ uid from traumatized peritoneal cavi-
ties was injected in the abdomen of naïve recipients, revealed an enhancement of the 
peritoneal recurrence in the naïve recipients. In the same in vivo rat model the lavage 
ﬂ uid was separated in a cellular and supernatant component and injected intra-perito-
neal without inﬂ icting additional surgical trauma. Intra-abdominal injection of the cellular 
component, composed of 75% PMNs, 10% lymphocytes and 5% macrophages, resulted 
in the highest tumour load compared to the effect of the supernatant component in this 
passive transfer model. Although the effect of the supernatant component was less impres-
sive, the outcome was still signiﬁ cant. The supernatant component contained cytokines 
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and growth factors, mainly produced by macrophages and monocytes. These factors 
were studied in successive in vitro studies with rat mesothelial and tumour cells. These 
investigations demonstrated that IL-1β and EGF are signiﬁ cant promoting factors in cell 
adhesion in vitro.71
In summary, these previous studies showed that surgical abdominal trauma stimulates 
tumour adhesion and growth in a rat model, probably caused by factors produced dur-
ing the inﬂ ammatory response after surgical trauma.
AIM OF THE THESIS
The complexity of the metastatic process necessitates the use and development of model 
systems that simulate human in vivo conditions as closely as possible. In this study we 
have reconstructed human mesothelium monolayers by culturing human mesothelial cells, 
derived from omental tissue of patients who underwent abdominal surgery. The mesothe-
lial cells were cultured on collagen coated ﬂ asks, which is a substitute of the extracellular 
matrix, since it is known that mesothelial cells rest upon a subcellular matrix. This system 
was employed to investigate the early interactions between human colon and pancreatic 
cancer cells and human mesothelial cells under well deﬁ ned conditions. Besides the 
development of the in vitro model, the aim of our study was to investigate the inﬂ uence 
of inﬂ ammatory factors (i.c. cytokines, X/XO, PMN’s, latex and serum) on the adhesion 
capacity of the mesothelium. In addition to the effect of these factors on the adhesion, 
we studied the expression and upregulation of adhesion molecules on the mesothelial 
cells and tumour cells.
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ABSTRACT
Surgical handling of the peritoneum has a dual character regarding cancer. In case of 
massive tissue damage, the ensuing inﬂ ammatory reaction produces a potentially lethal 
cocktail of active mediators, including cytokines and growth factors. The aim of this study 
was to investigate the effects of inﬂ ammatory cytokines, IL-1β, IL-6 and TNF-α, on the 
interaction between tumour cells and mesothelial cells. An experimental in vitro model 
was designed using Caco2 and HT29 colon carcinoma cells. For all studies, primary 
cultures of omentum derived mesothelial cells were used. Tumour cell adhesion to a 
mesothelial monolayer was assessed after overnight pre-incubation of the mesothelium 
with IL-1β, IL-6 and TNF-α. 
Pre-incubation of the mesothelial monolayer with IL-1β or TNF-α resulted in enhanced 
tumour cell adhesion of the Caco2 and HT29 cells. This effect was dose dependent. 
Maximum stimulation was achieved at 5 ng/ml (p< 0.01). The amount of stimulation 
for the Caco2 cells was between 20-40% versus the control situation and for HT29 
cells between 30-70%. IL-6 did not affect the tumour cell adhesion. Additional blocking 
experiments with anti-IL-1β and anti-TNF-α resulted in signiﬁ cant inhibition of the cytokine 
stimulated tumour cell adhesion, demonstrating the speciﬁ city of this effect.
The cocktail of intra-abdominal produced mediators have conﬂ icting demeanor regard-
ing wound healing and local tumour recurrence. The presented results prove that IL-1β 
and TNF-α are signiﬁ cant stimulating factors in tumour cell adhesion in vitro and may 
therefore account for tumour recurrence to the peritoneum in vivo.
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INTRODUCTION
Colorectal cancer accounts for over half of the cases of gastro-intestinal malignancy. 
Several new adjuvant treatment modalities improved the overall 5-year survival rate for 
colorectal carcinomas in the last decade. The most recent 5 year survival rates are, 
according to a study from France, 36% for local recurrence and 24% for distant me-
tastases.1 In the United States 80% of the patients with colorectal cancer present with 
local or locally advanced disease and for this group curative surgery can be attempted. 
However, up to 40% of these patients develop recurrent disease.2 Despite of the adjuvant 
chemotherapeutical therapies locoregional and distant recurrence is still a major problem 
with colorectal cancer. The most common site for colorectal adenocarcinoma to recur is 
the site of the primary tumour, the second is the peritoneal surface.3 Therefore, elimina-
tion of locoregional recurrence in the peritoneal cavity may be beneﬁ t a signiﬁ cant 
proportion of patients in terms of survival or quality of life. A profound understanding of 
the pathophysiology of tumour recurrence may lead to more speciﬁ c tools to confront the 
initial process of implantation.
Despite all peroperative precautions tumour spill and subsequent implantation, coloniza-
tion and growth of these cells in the peritoneal cavity on either intact or traumatized 
mesothelium and extracellular matrix is an important mechanism accounting for tumour re-
currence. Wound healing after surgical trauma induces an inﬂ ammatory response during 
which high amounts of cytokines and growth factors are produced.4-6 These inﬂ ammatory 
mediators are known to upregulate adhesion molecules and in that manner offering an 
exceptional environment for the tumour cells to adhere.7-9 
Aim of this study was to elucidate the role of cytokines with regard to inﬂ uencing seed-
ing and colonization of tumour cells to the surgically traumatized peritoneal surface. 
Therefore we developed an in vitro model in which we investigated the role of several 
major inﬂ ammatory cytokines, i.c. IL-1β, IL-6 and TNF-α, on the interaction between 
human mesothelial cells and colon carcinoma cells. We studied the adhesion of the 
Caco2 and HT29 cells on omental derived mesothelial cells. Furthermore, we studied 
the expression of adhesion molecules and counterparts on the cells used in this study by 
means of immunohistochemical staining in order to determine the potential interaction 
sites between the cells.
MATERIALS AND METHODS
Culture and identification of omental mesothelial cells
Mesothelial cells (MC) were obtained from the omental tissue of patients undergoing elective abdominal 
surgery. All patients have given informed consent. The MC were isolated according to techniques 
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modiﬁ ed from Nicholson et al. and Wu et al.10,11 The omentum was transferred to ﬂ uid containing 0.05% 
trypsin-0.02% EDTA (Invitrogen, Karlsruhe, Germany). After 15 minutes the detached MC were pelleted 
by centrifugation at 450 g for 10 minutes and were resuspended in RPMI 1640 supplemented with 10% 
foetal calf serum, L-glutamin (200 mmol/L) and penicillin (5000 U/ml)(Invitrogen, Karlsruhe, Germany). 
MC were grown to conﬂ uence in a 37ºC, fully humidiﬁ ed, 5% CO2 cabinet in polystyrene culture ﬂ asks 
(75 cm2, Corning BV, Schiphol-Rijk, The Netherlands), pre-coated with collagen type I (17.5 μg/ cm2 
). The identity of MC was demonstrated by the absence of Von Willebrand factor staining12 and the 
presence of intracellular cytokeratins13 via immunohistological staining with monoclonal antibodies (Dako, 
Amsterdam, The Netherlands).
Tumour cell line
The human colon adenocarcinoma Caco-2 and HT29 were kind gifts of Dr. W. Dinjens and are both 
mucinous adenocarcinoma. Both cell lines were cultured in RPMI medium supplemented with 10% foetal 
calf serum, L-glutamin (200 mmol/L) and penicillin (5000 U/ml). All supplements were obtained from 
Invitrogen, Karlsruhe, Germany. Before use, cells were trypsinized (5 minutes at 37ºC), centrifuged (5 
minutes at 400 g), resuspended in RPMI and counted. Viability was measured by trypan blue exclusion 
and always exceeded 95 percent.
Cytokine pre-incubation
Interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) were obtained from R&D 
Systems, Uithoorn, The Netherlands. Pre-incubation of the mesothelial monolayer and tumour cells was 
performed using increasing concentrations of these mediators. 
Anti-human IL-1β and anti-human TNF-α were obtained from R&D systems. To inactivate IL-β, pre-
incubation was performed with a hundred-fold excess of anti- IL-1β during 1 hour at 37 °C according 
to the instructions of the manufacturer. After this, the formed IL-1β/anti-IL-1β complex was added to the 
mesothelial monolayer for pre-incubation. Inactivation of TNF-α was performed in the same way as the 
inactivation of IL-1β. 
Calcein-AM solution and incubation
The dye solution, calcein-AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 μg calcein (Molecular Probes, Leiden, The Netherlands) in 5 μl anhydrous dimethyl sulphoxide 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) and adding this solution to 5 ml of RPMI 1640 medium 
supplemented with 0.5% bovine serum albumin (RPMI 1640/0.5%BSA, BSA obtained from Sigma-
Aldrich). Trypsinized Caco2 and HT29 cells (1x106 cells/ml) were incubated in RPMI1640/0.5%BSA at 
37 ºC for 30 minutes with occasional mixing.
Adhesion assay
To quantify tumour cell adhesion to a monolayer mesothelium, a standardised cell adhesion assay was 
developed according to methods from Catterall et al.14 Mesothelial monolayers were established in 96 
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well plates (Canberra Packerd, Groningen, The Netherlands), pre-coated with collagen type I (15 μg/
cm2, coating according to instructions of the manufacturer). To do this, conﬂ uent cells were washed with 
phosphate buffered saline (PBS) and harvested with trypsin (0.05%) and EDTA (0.02%) and 2.5 x 104 
mesothelial cells were added in 200 μl of medium to each well. The plates were incubated at 37 ºC, in 
a humidiﬁ ed atmosphere of 5% CO2 in air; medium was replaced daily with fresh medium. Monolayers 
reached conﬂ uence in 5 to 7 days as determined by light microscopy. In order to determine the effect 
of the inﬂ ammatory cytokines on tumour cell adhesion, mesothelial monolayers were pre-incubated with 
increasing doses. Non pre-incubated mesothelial monolayers served as controls.
Tumour cells were labelled with calcein as described above. Before adding to the mesothelial monolayers, 
the labelled cells were washed twice with RPMI1640/0.5%BSA to remove free dye.
Medium from the experimental wells was removed and 200 μl RPMI1640/0.5%BSA containing 30,000 
calcein labelled tumour cells was added. Plates were centrifuged for 1 minute at 80 g on a Perkin Elmer 
centrifuge and incubated at 37 ºC for 60 minutes. After this, the medium of each well was removed and 
washed twice with 200 μl RPMI1640/0.5% BSA medium. The remaining ﬂ uorescence per well was 
measured on a Perkin Elmer plate reader using 485 excitation and 530 emission ﬁ lters. On each plate a 
standard was prepared by adding different numbers of labelled tumour cells to the wells. The amount of 
tumour cells adhered was determined by calibrating the measured ﬂ uorescence of the experimental wells 
on the standard.
DNA-assay
To investigate whether overnight incubation of the mesothelial monolayer with the different cytokines was 
inﬂ uencing the cell growth, a DNA measurement was performed. In this assay, the DNA content of the 
mesothelial cells was measured using the bisbenzimide ﬂ uorescent dye (Roch Diagnostics) as previously 
described by Hoﬂ and et al.15 In short, at the end of the incubation period the plates were washed twice 
with saline and stored at -20°C until further analysis. The cells were extracted with ammonia solution 
(1 mmol/L) – Triton x 100 (0.2% v/v) by soniﬁ cation during 5 seconds at amplitude 15 (Soniprep 
150; MSE). Thereafter assay buffer (100 mmol/L NaCl, 10 mmol/L EDTA, 10 mmol/L Tris; pH 7.0) 
was added. The remaining solution was centrifuged at 2000 g during 5 min and 100 μl aliquots of 
the supernatant was mixed with 2 ml Hoechst dye H33258 (100 μg/L). Fluorescence was measured 
after 10 min with the excitation and emission wavelengths set at 350 and 455 nm respectively. The 
ﬂ uorescence of experimental samples were referenced to a standard curve of calf thymus DNA (type II; 
Sigma, Zwijndrecht, The Netherlands).
Growth curves
The effect of cytokines on tumour cell growth was investigated by incubating the tumour cell lines with 10 
ng/ml IL-1β, IL-6 or TNF-α overnight. Pre-incubation was initiated immediately after seeding of the tumour 
cells in 24 well plates. Growth response to IL-1β, IL-6 and TNF-α (R&D systems,Uithoorn, The Netherlands) 
was studied at the indicated time-points.
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Expression of cytokine receptors and adhesion molecules
Mesothelial cells and the colon carcinoma cell lines were prepared for staining by cytospin preparation, 
ﬁ xed in acetone for 1 minute and stored at –20 ºC until use. The cytospins were pre-incubated for 15 
minutes with 10% normal goat serum, diluted in PBS, and incubated overnight at 4 ºC with goat anti 
human monoclonal antibodies to IL-1 Ra, IL-6 R, TNF-RI, TNF-RII, ICAM-1, VCAM-1, CD44, LFA-1 and 
VLA-4 (all obtained from R&D systems).
Statistical analysis
All data were analysed using analysis of variance (ANOVA) to determine overall differences between 
group means. If the ANOVA was signiﬁ cant on a 5% level, the post-hoc Newman-Keuls test was carried 
out to make a comparison between groups. P≤ 0.05 was considered to be statistically signiﬁ cant. 
Experiments were carried out at least twice with comparable results.
RESULTS
Validation of assay
Loading of the tumour cells with calcein did not affect their viability (>95% using trypan 
blue). To determine the stability of calcein uptake, the release of ﬂ uorescence in the su-
pernatant of labelled cells after an incubation time of up to 120 minutes was measured. 
The ﬂ uorescence of the washed cells stayed constant for at least 90 minutes indicating 
retention of the dye in the cells (data not shown). A dilution series was made by using 
labelled Caco2 and HT29 cells on a mesothelial monolayer. There was a direct relation-
ship between the cell number added and measured ﬂ uorescence resulting in a linear 
correlation which was used as a standard to calibrate the measured ﬂ uorescence. In this 
way the amount of adhered tumour cells in the experimental wells could be determined.
Tumour cell adhesion to a mesothelial monolayer
Tumour cell adhesion to a non pre-incubated mesothelial monolayer was relatively slow 
and temperature dependent. Maximum adhesion was seen after 60 minutes. At this time 
point a steady state situation was achieved and cell adhesion did not increase hereafter. 
The tumour cells remained rounded up during these adhesion assays. After more than 60 
minutes, the ﬁ rst signs of spreading out could be detected under the light microscope. 
Therefore, for all subsequent experiments, 60 minutes was taken as a cut-off point. Non-
stimulated cell adhesion was always between 25-50% of the total amount of tumour cells 
added.
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Effect of cytokine pre-incubation
Pre-incubation of the mesothelial monolayer with IL-1β or TNF-α resulted in enhanced 
tumour cell adhesion of the Caco2 and HT29 cells. This effect was dose dependent. 
Maximum stimulation was achieved at 5 ng/ml (p< 0.01). The amount of stimulation 
for the Caco2 cells was between 20-40% versus the control situation and for HT29 cells 
between 30-70%. Contrary to IL-1β and TNF-α, IL-6 (1-100 ng/ml) did not altered the 
tumour cell adhesion to a mesothelial monolayer. Results are shown in ﬁ gure 1. After 
blocking with anti-IL-1β, stimulation with 1, 5 and 10 ng/ml IL-1β (0.1, 0,5 and 1 
μg/ml anti-IL-1β) was completely inhibited (ﬁ gure 2). 
Blocking with a hundred-fold excess of anti-TNF-α inhibited the stimulatory effect of TNF-α 
as well (ﬁ gure 2).
Pre-incubation of the tumour cells with IL-1β, TNF-α or IL-6 did not result in a signiﬁ cant 
increase of adhered tumour cells to the mesothelial monolayers (table 1).
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Figure 1
Tumour cell adhesion of Caco2 (A) and HT29 (B) to a mesothelial monolayer after pre-incubation 
of the monolayer with 0.5, 1, 5, 10, 50 and 100 ng/ml cytokine. Open bars represent IL-1β pre-
treated monolayers, closed bars the effect of IL-6 pre-treated monolayers and the blocked bars the 
effect of TNF-α. Values are the mean (n=6) +SEM. ∗p<0.01
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DNA-assay
Overnight pre-incubation of a mesothelial monolayer with IL-1β, IL-6 or TNF-α did not 
modify total DNA content of the mesothelial monolayer and therefore did not affect cell 
growth (ﬁ gure 3). To investigate the inﬂ uence of these cytokines on growing tumour cells, 
we measured the total DNA after 2 and 4 days of incubation of the tumour cells with 
IL-1β, IL-6 or TNF-α (10 ng/ml). The growth of Caco2 and HT29 cells was inhibited after 
Table 1
Control IL-1β TNF-α IL-6
% adhesion Caco2  45 ± 2 47 ± 3 35 ± 3 41 ± 4
% adhesion HT29 29 ± 2 31 ± 3 26 ± 4 33 ± 2
Tumour cell adhesion to a mesothelial monolayer after pre-incubation of the tumour cells with 
cytokines [5 ng/ml]. Value are the mean of n=6 ± SD.
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Figure 2
Tumour cell adhesion of Caco2 (A/C) and HT29 (B/D) to a mesothelial monolayer after pre-
incubation of the monolayer with 1, 5 and 10 ng/ml IL-1β (open bars ﬁ gure A and B) or TNF-α (open 
bars ﬁ gure C and D). The closed bars represent the additional blocking with anti IL-1β (A/B) or anti 
TNF-α (C/D). Values are the mean (n=6) +SEM. ∗p<0.01
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Figure 4
Growth rate of 20,000 Caco2 (A) and HT29 (B) cells incubated with cytokines IL-1β, IL-6 and TNF-α 
[10 ng/ml] during 4 days.
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Figure 3
The effect of IL-1β (open bars), IL-6 (closed bars) and TNF-α (blocked bars) on the proliferation of 
a mesothelial monolayer. Data are expressed as the mean (n=6) +SEM. Pre-incubation did not 
signiﬁ cantly modify total DNA of the monolayer.
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4 days when the cells were grown in RPMI 1640 10% FCS enriched with TNF-α or IL-6 
(10ng/ml). IL-1β (10ng/ml) incubation of Caco2 and HT29 cells resulted in a minor 
growth inhibition. (ﬁ gure 4) These results prove the functionality of the cytokine receptors 
on the tumour cells.
Expression of cytokine receptors and adhesion molecules
The results of the staining of mesothelial cells are shown in ﬁ gure 5 and clearly shows 
that these cells express receptors for IL-1β, IL-6 and TNF-α. 
C       D 
 A       B 
Figure 5
Expression of cytokine receptors by mesothelial cells. Figure A: negative control; B: IL-1β receptor; C: 
IL-6 receptor; D: TNF-α receptor.
Table 2
ICAM-1 VCAM-1 CD 44 LFA-1 VLA-4
mesotheel + + + - -
Caco2 + + + + +
HT29 + + + + +
Cell adhesion molecules and counterparts expressed by mesothelial, Caco2 and HT 29 cells 
according to the immunohistochemical staining.
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Table 2 exhibit the results of the immunohistochemical staining of the mesothelial cells 
and colon carcinoma cancer cell lines with the adhesionmolecules and counterparts. The 
mesothelial cells stain positive for ICAM-1, VCAM-1 and CD44. HT29 and Caco2 cell 
lines are both positive for ICAM-1, VCAM-1, CD44, LFA-1 and VLA-4. The negative con-
trols, the positive stained mesothelial cells and the counterparts on the colon carcinoma 
cell lines are shown in ﬁ gure 6. 
Mesothelium    HT 29    Caco-2 
A     B    C 
D     E    F 
G     H    I 
J     K    L 
Figure 6
Expression of cell adhesion molecules and counterparts after immunohistochemical staining of 
mesothelial, HT29 and Caco-2 cells. Figures A,B,C: negative control; D,E,F: CD44; G: ICAM-1; H, I: 
LFA-1; J: VCAM-1; K,L; VLA-4.
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DISCUSSION
Local recurrence of colorectal cancer is major clinical problem. Spilled tumour cells are 
preferential distributed to the resection site, and combined recurrences to the resection 
site and peritoneal surfaces are common.3 The mechanism behind this process has not 
been unravelled yet.
Following abdominal surgery there will be a reactive inﬂ ammatory response, the acute 
phase response, during which cytokines and growth factors are produced.16 These cyto-
kines are known to be conducive to wound healing by initiating the cellular cascade in 
the course of which macrophages and leukocytes migrate to the injured site.17 In addition 
to the predominantly production of cytokines by inﬂ ammatory cells, the mesothelial cells 
can also produce several chemokines during peritoneal injury.4,6 In our experiments we 
evaluated the effects of the cytokines IL-1β, Il-6 and TNF-α on the adhesion of colon 
carcinoma cells to mesothelial monolayers. IL-1β is one of the most investigated pro-
inﬂ ammatory cytokine and the concentration in postoperative peritoneal ﬂ uid increased 
signiﬁ cantly and therefore might be of great importance in the peritoneal cavity.18 IL-6 
is an early marker of tissue damage and the production of IL-6 by mesothelial cells is 
inﬂ uenced by IL-1 and TNF-α in a time and dose-dependent manner.19-21 TNF-α has a sig-
niﬁ cant function in the abdominal cavity and might modulate the inﬂ ammatory response 
by inducing the production of ILs from mesothelial cells.22,23 Postoperative concentrations 
of TNF-α in the peritoneal cavity are compared to IL-1β increased as well.18 
Our data advocate the enhancement of adhesion of Caco2 and HT29 cells to a meso-
thelial monolayer after incubation with IL-1β or TNF-α in a dose-dependent way. This ef-
fect was completely inhibited by blocking with anti-IL-1β and anti-TNF-α, which underline 
the speciﬁ city of IL-1β and TNF-α stimulation and the involvement of a speciﬁ c related 
pathway at which enhanced tumour cells adhesion to the mesothelial monolayer might 
be induced. Pre-incubation of the mesothelial monolayers with the different cytokines 
used in this study did not change the total DNA content and therefore demonstrate that 
the increased adhesion of colon carcinoma cells to the mesothelium is not caused by an 
enhanced number of mesothelial cells. Other investigators demonstrate the same effect 
of cytokines on the enhancement of adhesion with different tumour cell lines, like gastric 
tumour cells, melanoma cells and ovarian tumour cells.24-27 IL-1β and TNF-α are also 
potent stimulators of adhesion of colon carcinoma cells to endothelial cells.28 
The bell shape curves of cytokine stimulated adhesion are most likely caused by the fact 
that a high concentration of cytokine might stimulate mesothelial cells to produce media-
tors which can inhibit the stimulation of adhesion.29 Another explanation might be the 
down-regulation of cytokine receptors at high concentrations of the ligand.
The cytokines are not inﬂ uencing the growth of mesothelial cells in contrast to their 
inhibitory effect on the growth of the colon carcinoma cell lines. This inhibitory effect 
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demonstrate the functionality of the cytokine receptors on the colon carcinoma cell lines. 
Other studies have shown this suppressive effect of IL-1β and TNF-α on proliferating colon 
carcinoma cell lines as well.30-32 The inhibition of IL-6 on colon carcinoma cell growth 
was not studied before.
The enhancement of adhesion in this study is most likely originated by an upregulation 
of adhesion molecules. According to our immunohistochemical results mesothelial cells 
express ICAM-1, VCAM-1 and CD44. Caco2 and HT29 cells express, adjacent to the 
molecules expressed by the mesothelial cells, also the counterparts LFA-1 and VLA-4. 
These results suggest abundant possibilities for cell-cell and cell-matrix interactions under 
non-stimulated conditions. The expression patterns are similar to those observed in the 
literature. Several studies investigated the inﬂ uence of TNF-α and IL-1β on the expres-
sion of adhesion molecules on mesothelial cells. ICAM-1 and VCAM-1 expression is 
upregulated by these cytokines, which manifest the importance of these molecules in the 
interaction with colon carcinoma cells after stimulation of the mesothelium with IL-1β and 
TNF-α.7,8 
After stimulation of the colon carcinoma cell lines with the inﬂ ammatory cytokines there 
is no remarkable enhancement of the adhesion to the mesothelial monolayer, suggest-
ing that the mesothelial monolayer is the primary cell involved in increased adhesion 
induced by inﬂ ammatory cytokines. Expression of ICAM-1 on HT-29 and Caco2 cells is 
upregulated by TNFα and IL-β, however mesothelial cells do not express its counterpart 
LFA-1, which might be the explanation for the fact that there was not an enhancement 
of adhesion after stimulation of the colon carcinoma cell lines with the cytokines used in 
this study.33,34
In conclusion, inﬂ ammatory cytokines released following surgical wounding can cause 
an environment which is beneﬁ cial to tumour cell adhesion and possibly increases the 
metastatic potential of local tumour cells. This study demonstrate that the enhancement 
of colon carcinoma cells to a monolayer mesothelium is induced by IL-β and TNFα. This 
enhancement might be derived from an upregulation of ICAM-1, VCAM-1 and CD44 
on mesothelial cells. Future experiments has to source out which of the cell-cell and cell-
matrix interactions are the most important in tumour cell adhesion in order to develop 
site-speciﬁ c drug delivery systems and in that way block the tumour cells to adhere.
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CHAPTER 3
The expression of adhesion molecules and 
the inﬂ uence of inﬂ ammatory cytokines 
on the adhesion of human pancreatic 
carcinoma cells to mesothelial monolayers
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ABSTRACT
Pancreatic cancer has a tremendously deplorable prognosis. Peritoneal dissemination fre-
quently occur after surgical resection of the tumour. The aim of this study was to investigate 
the effects of inﬂ ammatory cytokines, IL-1β, IL-6 and TNF-α, on the interaction between 
pancreatic tumour cells and mesothelial cells. Primary cultures of mesothelial cells were 
incubated with the inﬂ ammatory cytokines and after the incubation the adherence of the 
different pancreatic cell lines was measured. By means of immunocytochemical staining 
and enzyme immunoassay, the expression of adhesion molecules was investigated.
Pre-incubation of the mesothelial monolayer with IL-1β or TNF-α resulted in enhanced 
tumour cell adhesion of the Mia-PaCa-2 and BxPC-3 cells. The amount of stimulation for 
the Mia-PaCa-2 cells was more than 100% versus the control situation and for BxPC-3 
cells between 20-35%. IL-6 did not affect the tumour cell adhesion of the Mia-PaCa-2 
and BxPC-3 cells. The adherence of Panc-1 was not enhanced after pre-incubation of 
the mesothelial monolayers with the inﬂ ammatory cytokines. Mesothelial cells show an 
signiﬁ cant enhancement of expression of ICAM-1, VCAM-1 and CD44 after stimulation 
with IL-1β and TNF-α.
The presented results prove that IL-1β and TNF-α are signiﬁ cant stimulating factors in 
pancreatic tumour cell adhesion in vitro and may therefore account for tumour recurrence 
to the peritoneum in vivo. The immunocytochemical staining results demonstrate that 
ICAM-1 and CD44 important adhesion molecules and interference with their function 
may decrease the incidence of peritoneal tumour recurrence after curative resection of 
pancreatic cancer.
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INTRODUCTION
Pancreatic cancer has a very poor prognosis and is often in an advanced state of 
disease at the time of diagnosis. In the ﬁ rst year more than 90% patients die and the 5-
year survival is less than 5%. The intra-abdominal recurrence rate after curative resection 
ranged between 38% and 86%.1-3 The most common site of local recurrence is the resec-
tion site, but all the traumatized peritoneal sites are at risk for tumour cell entrapment. The 
mechanism of local recurrence is still poorly understood. 
In blood-borne metastasis the attachment of carcinoma cells to endothelial cells is a cru-
cial step. The endothelium is activated by inﬂ ammatory cytokines and polymorphonuclear 
leukocytes or lymfocytes adhere to the activated endothelium. In the same manner tumour 
cells attach to the endothelium. This process is mediated by E-selectin on the endothelial 
cells and Slea on the pancreatic tumour cells. 4 Contrary to blood-borne metastasis studies 
on pancreatic cancer, very few studies report on the mechanism of local tumour recur-
rence. The ﬁ rst study in which local recurrence of pancreatic tumour cells to components 
of the extracellular matrix has been investigated was done in 1981 by McIntyre et al. 
This study shows that the adhesion of MiaPaCA-2 cells to collagen is stimulated by 
ﬁ bronectin, present in fetal bovine serum.5 In other studies the pancreatic tumour cells 
are stimulated and exposed to the extracellular matrix.6,7 Beside the extracellular matrix 
the traumatized peritoneum may induce the release cytokines and growth factors. Our 
study is based on the theory that these inﬂ ammatory mediators upregulate the adhesion 
molecules on the mesothelial cells and in that way causes an enhancement of adhesion 
of tumour cells to the peritoneum.8-12
In the present study, we developed an in vitro adhesion model to quantify the adhe-
sion of three human pancreatic cell lines to cytokine activated mesothelial monolayers. 
The pancreatic tumour cell lines we used were Panc-1 and Mia-PaCa-2, which are 
non-metastatic cell lines, and BxPC-3, which is a metastatic cell line.13 The aim of this 
reproducible model was to demonstrate the effect of inﬂ ammatory cytokines, produced 
after surgical trauma, on the adhesion of tumour to the mesothelium in vitro. Little is known 
about the expression of adhesion molecules (ICAM-1 and VCAM-1) and counterparts 
(LFA-1 and VLA-4) on the pancreatic tumour cell lines. Therefore the pancreatic carcinoma 
cell lines and the mesothelium were analyzed by means of immunocytochemical staining 
to investigate the expression of adhesion molecules and counterparts in order to verify 
important interactions between the investigated cell types. Following the results of the 
immunocytochemistry, analysis of the upregulation of adhesion molecules was done by 
means of Enzyme Immuno Elisa (EIA).
Helma BW 4.indd   44 03-05-2007   14:26:12
Cytokines and adhesion of pancreatic carcinoma cells 45
MATERIALS AND METHODS
Culture and identification of omental mesothelial cells
Mesothelial cells (MC) were obtained from the omental tissue of patients undergoing elective abdominal 
surgery who had given informed consent. The experimental protocol was approved by the Medical 
Ethical Committee of the Erasmus Medical Center Rotterdam, The Netherlands. The MC were isolated 
according to techniques modiﬁ ed from Nicholson et al. and Wu et al.14,15 The omentum was transferred 
to ﬂ uid containing 0.05% trypsin-0.02% EDTA (Invitrogen, Karlsruhe, Germany). After 15 minutes the 
detached MC were pelleted by centrifugation at 1800 rpm for 10 minutes and were resuspended in 
RPMI 1640 supplemented with 10% foetal calf serum, L-glutamin (200 mmol/L) and penicillin (5000 
U/ml)(Invitrogen, Karlsruhe, Germany). MC were grown until conﬂ uence in a 37ºC, fully humidiﬁ ed, 
5% CO2 cabinet in polystyrene culture ﬂ asks (75 cm
2, Corning BV, Schiphol-Rijk, The Netherlands) pre-
coated with collagen type I (17.5 μg/ cm2 ). The identity of MC was demonstrated by the absence of 
Von Willebrand factor (F8) and the presence of intracellular keratin and vimentin via immunocytochemical 
staining with monoclonal antibodies (Dako, Amsterdam, The Netherlands).16,17 We only used pure cultures 
of MC for our experiments. The immunocytochemical stainings of the MC are shown in ﬁ gure 1.
A B
C
Figure 1
Immunocytochemical staining of mesothelial cells for keratin (A), vimentin (B) and Von Willebrand 
factor (C).
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Tumour cell line
The pancreatic carcinoma cell lines, Panc-1, Mia-PaCa-2 and BxPC-3 were kind gifts of Dr. W. Dinjens. 
All cell lines were cultured in RPMI1640 medium supplemented with 10% foetal calf serum, L-glutamin 
(200 mmol/L) and penicillin (5000 U/ml). All supplements were obtained from Invitrogen, Karlsruhe, 
Germany. Before use, cells were trypsinized (5 minutes at 37ºC), centrifuged (5 minutes at 1500 rpm), 
resuspended in RPMI 1640 and counted. Viability was measured by trypan blue exclusion and always 
exceeded 95 percent.
Cytokine pre-incubation
Interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) were obtained from R&D 
Systems, Uithoorn, The Netherlands. Pre-incubation of the mesothelial monolayer and tumour cells was 
performed using increasing concentrations of these mediators. 
Calcein-AM solution and incubation
The dye solution, calcein-AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 μg calcein (Molecular Probes, Leiden, The Netherlands) in 5 μl anhydrous dimethyl sulphoxide 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) and adding this solution to 5 ml of RPMI 1640 
medium supplemented with 0.5% bovine serum albumin (RPMI 1640/0.5%BSA, BSA obtained from 
Sigma-Aldrich). Trypsinized Panc-1, MiaPaCa-2 and BxPC-3 cells (1x106 cells/ml) were incubated in 
RPMI1640/0.5%BSA at 37 ºC for 30 minutes with occasional mixing.
Adhesion assay
To quantify tumour cell adhesion to a monolayer mesothelium, a standardized cell adhesion assay was 
developed according to methods from Catterall et al..18 Mesothelial monolayers were established in 96 
well plates (Canberra Packerd, Groningen, The Netherlands), pre-coated with collagen type I (15 μg/
cm2, coating according to instructions of the manufacturer). To do this, conﬂ uent cells were washed with 
phosphate buffered saline (PBS) and harvested with trypsin (0.05%) and EDTA (0.02%) and 2.5 x 104 
mesothelial cells were added in 200 μl of medium to each well. The plates were incubated at 37 ºC, in 
a humidiﬁ ed atmosphere of 5% CO2 in air; medium was replaced daily with fresh medium. Monolayers 
reached conﬂ uence in 5 to 7 days as determined by light microscopy. In order to determine the effect 
of the inﬂ ammatory cytokines on tumour cell adhesion, mesothelial monolayers were pre-incubated with 
increasing doses. Non pre-incubated mesothelial monolayers served as controls.
Tumour cells were labeled with calcein as described above. Before adding to the mesothelial monolayers, 
the labeled cells were washed twice with RPMI1640/0.5%BSA to remove free dye.
Medium from the experimental wells was removed and 200 μl RPMI1640/0.5%BSA containing 30,000 
calcein labeled tumour cells was added. Plates were centrifuged for 1 minute at 80 g on a Perkin Elmer 
centrifuge and incubated at 37 ºC for 60 minutes. After this, the medium of each well was removed and 
washed twice with 200 μl RPMI1640/0.5% BSA medium. The remaining ﬂ uorescence per well was 
measured on a Perkin Elmer plate reader using 485 excitation and 530 emission ﬁ lters. On each plate a 
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standard was prepared by adding different numbers of labeled tumour cells to the wells. The amount of 
tumour cells adhered was determined by calibrating the measured ﬂ uorescence of the experimental wells 
on the standard.
Expression of adhesion molecules and their counterparts
Mesothelial cells and the pancreatic tumour cell lines were prepared for staining by cytospin preparation, 
ﬁ xed in acetone for 1 minute and stored at –20 ºC until use. The cytospins were pre-incubated for 15 
minutes with 10% normal goat serum, diluted in PBS, and incubated overnight at 4 ºC with goat anti 
human monoclonal antibodies to ICAM-1, VCAM-1, CD44, LFA-1 and VLA-4 (all obtained from R&D 
systems). 
Enzyme Immuno Assay (EIA)
An enzyme immunoassay was used to determine the effect of the cytokines on the expression of adhesion 
molecules. Mesothelial cells were grown to conﬂ uence in 96-well ﬂ at-bottomed multititer plates and 
pre-incubated with either cell culture medium alone or combined with IL-1β, IL-6 or TNF-α for 12 hours. 
Medium from the experimental wells was removed and the cells were ﬁ xed in 95% ethanol/ 5% methanol 
solution for 45 minutes. Subsequently, the cells were pre-incubated for 10 minutes with 1% normal goat 
serum, diluted in PBS, to inactivate unspeciﬁ c binding. Mouse anti-human monoclonal antibodies to ICAM-
1 (CD54, R&D Systems), VCAM-1 (CD106, R&D Systems), CD44 (CD106, R&D Systems) was added for 
60 minutes. The cells were subsequently incubated with biotinylated goat antimouse antibody (Sigma-
Aldrich Chemie, Zwijndrecht, the Netherlands) in a dilution of 1 : 500 for another 60 minutes. Finally 
the cells were incubated with a Streptavidin-peroxidase complex for 30 minutes, washed, and substrate 
(2,2’-azino-bis(3-ethylbenthiazoline-6-sulfonic acid) in 0,05M phosphate-citrate buffer containing 0,03% 
sodium perborate was added. Incubation of tumour cells or mesothelial cells without the primary antibody 
served as a negative control. After 40 minutes, the reaction was stopped using 0,4% sodium ﬂ uoride. 
Photometrical evaluation was performed with a computer-controlled ELISA-plate reader at λ = 405 nm.
Statistical analysis
All data were analyzed using analysis of variance (ANOVA) to determine overall differences between 
group means. If the ANOVA was signiﬁ cant on a 5% level, the post-hoc Newman-Keuls test was carried 
out to make a comparison between groups. P ≤ 0.05 was considered to be statistically signiﬁ cant. 
Experiments were carried out at least twice with comparable results.
RESULTS
Validation of assay
Loading of the tumour cells with calcein did not affect their viability (>95% using trypan 
blue). To determine the stability of calcein uptake, the release of ﬂ uorescence in the 
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supernatant of labeled cells after an incubation time of up to 120 minutes was measured. 
The ﬂ uorescence of the washed cells stayed constant for at least 90 minutes indicating 
retention of the dye in the cells (data not shown). A dilution series was made by using 
labeled Panc-1, MiaPaCa-2 and BxPC-3 cells on a mesothelial monolayer. There was a 
direct relationship between the cell number added and measured ﬂ uorescence resulting 
in a linear correlation which was used as a standard to calibrate the measured ﬂ uores-
cence. In this way the amount of adhered tumour cells in the experimental wells could 
be determined.
Tumour cell adhesion to a mesothelial monolayer
Tumour cell adhesion to a non pre-incubated mesothelial monolayer was relatively slow 
and temperature dependent. Maximum adhesion was seen after 60 minutes. At this time 
point a steady state situation was achieved and cell adhesion did not increase hereafter. 
The tumour cells remained rounded up during these adhesion assays. After more than 60 
minutes, the ﬁ rst signs of spreading out could be detected under the light microscope. 
Therefore, for all subsequent experiments, 60 minutes was taken as a cut-off point. 
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Figure 2
Tumour cell adhesion of Panc-1 (A), MiaPaCa-2 (B) and BxPC-3 (C) to a mesothelial monolayer 
after pre-incubation of the monolayer with 0.5, 1, 5, 10, 50 and 100 ng/ml cytokine. Open bars 
represent IL-1-β pre-treated monolayers, closed bars the effect of IL-6 pre-treated monolayers and the 
blocked bars the effect of TNF-α. Values are the mean (n=6) +SEM. *p<0.01 vs. control.
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Effect of cytokine pre-incubation
Overnight incubation of a mesothelial monolayer with IL-1β, IL-6 or TNF-α did not modify 
total DNA content of the mesothelial monolayer and therefore did not affect cell growth 
(data not shown). 
The adhesion of the Panc-1 cells in the control situation was 49%. Pre-incubation of the 
mesothelial monolayer with IL-1β, IL-6 or TNF-α did not resulted in enhanced tumour cell 
adhesion of the Panc-1 cells (ﬁ gure 2A). 
In the control situation the adhesion of Mia PaCa-2 cells was 13%. Pre-incubation of the 
mesothelial cells with IL-1β or TNF-α resulted in an signiﬁ cant enhancement of adhesion 
of the MiaPaCa-2 cells of more than 100%. Pre-incubation with IL-6 had no effect on the 
adhesion (ﬁ gure 2B).
In the control group 28% of the BxPC-3 cells adhere to the mesothelium. Pre-incubation 
of the mesothelial cells with IL-1β or TNF-α caused an enhancement of the adhesion of 
the BxPC-3 cells. This enhancement was for IL-1β and TNF-α dose-dependent, with a 
maximum stimulation at respectively 1 and 5 ng/ml (p<0.01). The amount of stimulation 
was for the BxPC-3 cells between 20-35% versus the control situation. Contrary to IL-1β 
and TNF-α, IL-6 (1-100 ng/ml) did not altered the tumour cell adhesion to a mesothelial 
monolayer (ﬁ gure 2C).
Expression of adhesion molecules and counterparts
The results of the immunocytochemical staining of the mesothelial cells and the three 
pancreatic cancer cell lines are shown table 1. The mesothelial cells stain positive for 
ICAM-1, VCAM-1 and CD44. Panc-1 is positive for ICAM-1, VCAM-1 and CD44. 
MiaPaCa-2 is positive only for CD44 and the BxPC-3 cells stain positive for ICAM-1, 
CD44 and LFA-1. 
The EIA is a semi quantitative assay giving the opportunity to investigate the dynamics of 
expression of adhesion molecules on mesothelial cells with or without stimulating the cells 
with IL-1β, IL-6 or TNF-α (in optical density (OD) units measured at 405 nm). The staining 
intensity for ICAM-1 of unstimulated mesothelial cells was 0.623, whereas the negative 
control gave an intensity of 0.118, indicating a marked basal expression of ICAM-1 
on mesothelial cells (ﬁ gure 3A). Optical density (OD) for VCAM-1 on mesothelial cells 
Table 1
ICAM-1 VCAM-1 CD 44 LFA-1 VLA-4
mesothelium + + + - -
Panc1 + + + - -
Miapaca2 - - + - -
Bxpc3 + - + + -
Cell adhesion molecules (ICAM-1, VCAM-1 and CD 44) and counterparts (LFA-1, VLA-4) expressed 
by mesothelial, Panc-1, MiaPaCa-2 and BxPC-3 cells.
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and the negative control were 0.505 and 0.137 respectively. And the optical density 
for CD44 on mesothelial cells was 0.342 with a negative control of 0.184, indicating 
that mesothelial cells have a basal expression of VCAM-1 and CD44 as well (ﬁ gure 
3B,C). Overnight incubation of the mesothelial cells with TNF-α resulted in an enhanced 
expression of ICAM-1 (mean OD 0.73) and VCAM-1 (mean OD 0.65). Stimulating 
the mesothelial cells with IL-1β for 12 hours a signiﬁ cant overexpression of ICAM-1 
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Figure 3
Expression of ICAM-1 (A), VCAM-1 (B) and CD44 (C) on mesothelial cells stimulated with IL-1β, TNF-
α or IL-6. *p<0.01 vs. control. (OD = optical density units measured at 405 nm)
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(mean OD 0.74) and CD44 (mean OD 0.49) could be observed. Incubation of the 
mesothelial cells with IL-6 has no inﬂ uence on the expression of the adhesion molecules 
(ﬁ gure 3A-C).
DISCUSSION
Pancreatic cancer has a poor prognosis. Only 15-20% of the patients with pancreatic 
cancer have a resectable tumour at the time of diagnosis. Complete macroscopically 
resection of the tumour does not prevent the development of early recurrences at the 
resection site or the peritoneum. This study provides an insight in the mechanism of inva-
sion and implantation of cancer cells to the resection site or peritoneum after curative 
surgery. 
Cytokines produced during surgery are known to inﬂ uence tumour recurrence in vivo.19-21 
Surgical trauma causes an inﬂ ammatory response during which leucocytes and mac-
rophages migrate to the injured site in order to promote wound healing.22 Mesothelial 
cells, lining the peritoneum have an active part in the inﬂ ammatory process by producing 
a variety of cytokines such as IL-1β and IL-8.8,23 This will cause a rich micro-environment 
at traumatized peritoneal sites with high concentrations cytokines and growth factors. 
This study investigated the adherence pattern of three pancreatic tumour cell lines to 
mesothelial monolayers. Pre-treatment of the monolayer mesothelium with IL-1β or TNF-α 
causes an upregulation of adhesion of the MiaPaCa-2 and BxPC-3 cells. The adhesion 
of Panc-1 cells is not enhanced after stimulation of the mesothelium with the cytokines 
used in this study, probably caused by the high amount of adhered tumour cells in the 
control situation. Overnight pre-incubation of the mesothelial monolayer with IL-1β, IL-6 or 
TNF-α did not modify total DNA content of the mesothelial monolayer and therefore did 
not affect cell growth. This suggests that the increased adhesion induced by IL-1β and 
TNF-α is not caused by an increased number of mesothelial cells and that these cytokines 
are not inﬂ uencing conﬂ uent monolayers. 
Studies on cell adhesion have been done to investigate the adhesion of leucocytes 
on endothelial and mesothelial cells during inﬂ ammation. These studies conclude that 
leucocyte enrolling is caused by an upregulation of ICAM-1, VCAM-1, E-selectin and P-
selectin on endothelial or mesothelial cells and in that way induces leucocyte attachment 
and extravasation.8, 24-26 Tumour cells may utilize this upregulated expression of adhesion 
molecules and in that way adhere to the mesothelium.
The mechanism of adhesion of pancreatic cells to mesothelial cells has not been in-
vestigated extensively. Hosono et al. studied the adhesion of the SW1990 cell line 
to mesothelial cells and investigated that antibodies against integrin β1 and CD44 
can block the adhesion to mesothelium. CD44 and integrin play important roles in the 
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initial attachment of SW1990 cells to mesothelial cells.27 In haemotogenic metastasis of 
pancreatic tumours E-selectin and the counterpart sialylated Lewisa on tumour cells plays 
an important role. This process is enhanced by cytokines IL-1β and TNF-α.4 
Investigations on expression of integrins and attachment to the extracellular matrix proteins 
are ample. β1 integrins on different pancreatic carcinoma cell types have various levels 
of constitutive activity and pancreatic carcinoma cells with higher constitutive activity of 
β1 integrin are more invasive. Blocking this integrin inhibited the invasion of pancreatic 
carcinoma cells. Cytokines modulate the integrin expression and in that way enhance the 
attachment of pancreatic tumour cells to the extracellular matrix.6, 28-30 
Very few studies report on the expression of adhesion molecules and counterparts on pan-
creatic tumour cells. The expression of adhesion molecules on the cells used in this study 
are conclusive for different possibilities for cell-cell and cell-matrix interaction under non 
stimulated condition. In the stimulated situation IL-1β causes an signiﬁ cant enhancement 
of expression of VCAM-1 and CD44 on mesothelial cells. Incubation of the mesothelial 
cells with TNF-α increased the expression of ICAM-1 and VCAM-1. IL-6 is not inﬂ uencing 
the expression of the studied adhesion molecules on mesothelial cells, and therefore not 
enhancing the adhesion of pancreatic tumour cells to mesothelial monolayers in the adhe-
sion assay. From the known interaction of adhesion molecules, these results suggest that 
CD44 and ICAM-1 are important molecules in the adhesion of pancreatic tumour cells 
to mesothelial cells. Although TNF-α upregulates VCAM-1 as well, VCAM-1 is not a key 
adhesion molecule in this model, because the counterpart VLA-4 is not expressed by the 
pancreatic tumour cell lines. Only BxPC-3 can beneﬁ t from overexpression of ICAM-1 on 
the mesothelial cells because this pancreatic cell line expresses the counterpart LFA-1.
Tumour cell invasion and metastasis is a multistep process that involves also a variety of 
cell surface receptors that mediate interactions with the mesothelial cells, extracellular 
matrix and endothelial cells. This study comes up with an comprehension of the adhe-
sion pattern of three different pancreatic tumour cell lines to mesothelial cells and an 
overview of the expression of adhesion molecules and their counterparts on the tumour 
and mesothelial cells. Our data suggest that the adhesion is enhanced by stimulation 
of the mesothelial cells with cytokines IL-1β and TNF-α. These cytokines are produced 
during surgery and upregulates adhesion molecules and can cause in that manner local 
tumour recurrence of spilled tumour cells. Interference with the function of cell adhesion 
molecules may decrease the incidence of local and distant metastasis and enhance the 
prognosis of patients with pancreatic cancer after surgery. In future studies the mechanism 
of adhesion of tumour cells has to be unraveled further and in that way prevent tumour 
recurrence after curative resection of pancreatic cancer.
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ABSTRACT
Tissue injury induces the acute phase response, aimed at minimizing damage and start-
ing the healing process. Polymorphonuclear leukocytes (PMN) respond to the presence 
of speciﬁ c chemoattractants and begin to appear in large numbers. The aim of this study 
is to investigate the inﬂ uence of reactive oxygen species (ROS) produced by PMN on 
the interaction between colon carcinoma cells and mesothelial cells. Tumour cell adhe-
sion to a mesothelial monolayer was assessed after pre-incubation of the mesothelium 
with stimulated PMN and unstimulated PMN. Mesothelial cells were also incubated 
with Xanthine/Xanthine Oxidase (X/XO) complex producing ROS after which adhesion 
of Caco-2 cells was investigated and the expression of adhesion molecules (ICAM-1, 
VCAM-1 and CD44) by means of enzyme immunoassay (EIA). 
In the control situation the average adhesion of Caco2 cells to the mesothelial monolay-
ers was 23%. Mesothelial monolayers incubated with unstimulated PMN showed a 25% 
increase of tumour cell adhesion (p<0.05). The adhesion of tumour to the monolayers 
incubated with the FMLP stimulated PMN increased with 40% (p<0.01). Incubation of 
the mesothelium with X/XO resulted in an enhancement of adhesion of Caco-2 cells of 
70% and an upregulation of expression of ICAM-1, VCAM-1 and CD44.
 This study reveals an increase of tumour cell adhesion to the mesothelium induced by 
incubating the mesothelial monolayers with PMN. PMN are producing a number of 
products, like proteolytic enzymes, cytokines and reactive oxygen species (ROS). These 
factors upregulate the expression of adhesion molecules and in that way stimulate the 
adhesion of tumour to the mesothelium. 
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INTRODUCTION
Surgical treatment of gastro intestinal malignancies is often complicated by locoregional 
tumour recurrence 1. Regardless this detrimental adversity, surgery remains the best treat-
ment option. Therefore, many attempts have been undertaken, in clinical and research 
settings, to elucidate the effect of surgical trauma on tumour recurrence. In a clinical trial, 
Busch et al. put forward an association between tumour recurrence and the extent of sur-
gical injury 2. In experimental models, post surgically produced factors have been shown 
to augment local and remote tumour growth. Experimental and clinical studies have 
demonstrated that enhanced tumour cell adherence and tumour growth are inevitable 
repercussions of surgical trauma 1,3-7. 
Nowadays, there is a growing interest in the pathophysiological mechanism on the basis 
of which surgical trauma leads to enhanced tumour recurrence.
Surgery is an inﬂ ammatory stimulus that activates the body’s immune response. The ensu-
ing inﬂ ux of polymorph nuclear leukocytes (PMN) and mononuclear cells to the surgically 
traumatized site is mediated through chemotactic factors and pro-inﬂ ammatory cytokines 
such as IL-1β or TNF-α and is the ﬁ rst line of defense.8,9
Insights in the host defense mechanisms of the peritoneum have demonstrated that peri-
toneal lymphocytes, submesothelial monocytes, PMN and mesothelial cells act in an 
orchestrated response under the control of locally expressed cytokines, chemokines and 
adhesion molecules. The peritoneal membrane and the mesothelium in particular, as a 
site for the production of mediators, play a pivotal role in the activation and control of 
inﬂ ammation.10,11 
In previous studies we demonstrated that the inﬂ ammatory sequelae after surgery promote 
tumour recurrence and that this effect is mainly based on the cellular component of the 
inﬂ ammatory process. Analysis of the cellular fraction reveals a trauma related inﬂ ux of 
PMN into the abdominal cavity (van Rossen et al. unpublished). Comparable shifts in cell 
differentiation have also been demonstrated in other animal models following peritoneal 
trauma as well.9,12 PMN are known to produce reactive oxygen species (ROS) to destroy 
invading organisms, beside this beneﬁ cial effect, the overwhelming oxidative potential 
can result in additional tissue destruction.13,14,15
The aim of this study was to investigate the effect of unstimulated and FMLP (N-formyl-
methionyl-leucyl-phenylalanine) stimulated PMN on the adhesion of Caco-2 cells, a hu-
man colon carcinoma cell line, on mesothelial monolayers. To evaluate our hypothesis 
that ROS, produced by PMN, are the source of the enhancement of adhesion we also 
investigated the direct effect of reactive oxygen species produced by the interaction 
of xanthine (X) and xanthineoxidase (XO) on tumour cell adhesion. Finally, we studied 
the expression of adhesion molecules on mesothelial cells after incubation with X/XO 
products by means of enzyme immunoassay (EIA).
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MATERIALS AND METHODS
Culture and identification of omental mesothelial cells
Mesothelial cells (MC) were obtained from the human omental tissue. The experimental protocol was 
approved by the Medical Ethical Committee of the Erasmus Medical Centre Rotterdam, The Netherlands. 
The MC were isolated according to techniques modiﬁ ed from Nicholson et al.16 and Wu et al.17. The 
omentum was transferred to ﬂ uid containing 0.05% trypsin-0.02% EDTA (Invitrogen, Karlsruhe, Germany). 
After 15 minutes the detached MC were pelleted by centrifugation at 1800 rpm for 10 minutes and were 
resuspended in RPMI 1640 supplemented with 10% fetal calf serum, L-glutamin (2 mmol/L) and penicillin 
(105 U/ml) (Invitrogen, Karlsruhe, Germany). MC were grown until conﬂ uence in a 37ºC, fully humidiﬁ ed, 
5% CO2 cabinet in polystyrene culture ﬂ asks (75 cm
2, Corning BV, Schiphol-Rijk, The Netherlands) pre-
coated with collagen type I (17.5 μg/ cm2 ). The identity of MC was demonstrated by the absence of 
Von Willebrand factor staining 18 and the presence of intracellular cytokeratins 19 via immunohistological 
staining with monoclonal antibodies (Dako, Amsterdam, The Netherlands).
Caco-2 cell line
The human colon adenocarcinoma Caco-2 was a kind gift of Dr. W. Dinjens. The cell line was cultured 
in RPMI1640 medium supplemented with 10% fetal calf serum, L-glutamin (2 mmol/L) and penicillin 
(105 U/ml). All supplements were obtained from Invitrogen, Karlsruhe, Germany. Before use, cells were 
trypsinized (5 minutes at 37ºC), centrifuged (5 minutes at 1500 rpm), resuspended in RPMI 1640 and 
counted. Viability was measured by trypan blue exclusion and always exceeded 95 percent.
Isolation of Polymorphonuclear leukocytes (PMN)
Human blood was drawn by venipuncture from healthy volunteers into a sterile syringe containing heparin. 
PMN were prepared using the standard techniques of dextran sedimentation followed by Histopaque 
1077 gradient centrifugation. Residual erythrocytes were removed by hypotonic lysis and PMN were 
resuspended in buffered salt solution (BSS) (138 mmol/l NaCl, 2.7 mmol/l KCl, 8.1 mmol/l Na2HPO4, 
1.5 mmol/l KH2PO4, 1 mmol/l MgCl2, 1 mmol/l CaCl2 , pH 7.4) supplemented with 1 mg/ml glucose 
and 1 mg/ml human serum albumine (HAS). Purity of the ﬁ nal cell suspension and cell viability, assessed 
by trypan blue exclusion test, were > 95% in all cases. 
Superoxide (O2
-) production by stimulated PMN with FMLP
PMN were suspended in buffer saline solution (BSS); they were pretreated with cytochalasin B (5 g/ml) 
for 5 min at 37ºC to maximize the measured response, then challenged with the test compound for 15-25 
min at 37ºC before exposure to 10-7M FMLP (N-formyl-methionyl-leucyl-phenylalanine) for a further 5 min. 
O2
- production was determined spectrophotometrically by measuring the superoxide dismutase inhibitable 
reduction of cytochrome c reduced/106 PMN/min as described below.
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Xanthine / Xanthine Oxidase superoxide generating system 
The reactive oxygen species (ROS) superoxide and hydrogen peroxide were generated by Xanthine 
Oxidase (XO) (0.05 U/ml, Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) upon addition of 
Xanthine (X) (0.1 mmol/l, Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands). The oxygen-free radicals 
are produced by the following enzymatic reaction: Xanthine + O2 + H2O à Uric Acid + H2O2 + O2, 
catalyzed by Xanthine Oxidase (XO).
Superoxide generation by X/XO was determined using the ferricytochrome C reduction techniques 
modiﬁ ed from Leslie et al.20 In brief, cytochrome c (cytc) was prepared in HBSS without phenol red 
and used at a ﬁ nal concentration of 150μM. All solutions were pre-warmed to 37ºC. The assay was 
performed as six-fold replicates by ﬁ lling the wells in vertical rows. Initially cytc or cytc + xanthine (100 
μl/well) was distributed in the rows. The rows were then ﬁ lled with xanthine oxidase solution (100 
μl/well). An extra row was ﬁ lled with cytc and HBSS only to provide a control. Immediately after adding 
the xanthine oxidase the plate was read (t=0) and every 10 minutes afterwards, with 120 minutes as 
endpoint. The plate was kept at a constant temperature of 37ºC. The amount of cytc reduction at 37°C 
was determined by taking kinetic measurements of absorbance at 540 and 550 nm using a Thermomax 
double-beam microplate reader. The cumulative superoxide production is shown as optical density (OD) 
by deducting the OD at 550 nm from the OD measured at 540 nm. The super oxide production is 
expressed in nanomoles per minutes per 107 cells.21
Tumour cell labeling and incubation 
The dye solution, calcein-AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 μg calcein (Molecular Probes, Leiden, The Netherlands) in 5 μl anhydrous dimethyl sulphoxide 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) and adding this solution to 5 ml of RPMI 1640 medium 
supplemented with 0.5% bovine serum albumin (RPMI 1640/0.5%BSA, BSA obtained from Sigma-
Aldrich). Trypsinized Caco2 cells (1x106 cells/ml) were incubated in RPMI1640/0.5%BSA at 37 ºC for 
30 minutes with occasional mixing. Before adding to the mesothelial monolayers, the labelled cells were 
washed twice with RPMI1640/0.5%BSA to remove free dye.
Tumour cell adhesion assay
To quantify tumour cell adhesion to a monolayer mesothelium, a standardized cell adhesion assay was 
developed according to methods from Catterall et al.22 Mesothelial monolayers were established in 96 
well plates (Canberra Packerd, Groningen, The Netherlands), pre-coated with collagen type I (15 μg/cm2, 
coating according to instructions of the manufacturer). To do this, conﬂ uent cells were washed with phosphate 
buffered saline (PBS) and harvested with trypsin (0.05%) and EDTA (0.02%) and 2.5 x 104 mesothelial 
cells were added in 200 μl of medium to each well. The plates were incubated at 37 ºC, in a humidiﬁ ed 
atmosphere of 5% CO2 in air; medium was replaced daily with fresh medium. Monolayers reached 
conﬂ uence in 5 to 7 days as determined by light microscopy.
Mesothelial monolayers were incubated with unstimulated PMN and FMLP stimulated PMN in a transwell 
system (Corning Incorporated Life Sciences, U.S.A.)overnight. The next day the transwells were removed en 
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the mesothelial cells were incubated with the Caco-2 cells. Non pre-incubated mesothelial monolayers served 
as controls.
Tumour cells were labeled with calcein as described above. Before adding to the mesothelial monolayers, 
the labeled cells were washed twice with RPMI1640/0.5%BSA to remove free dye. Medium from the 
experimental wells was removed and 200 μl RPMI1640/0.5%BSA containing 30,000 calcein labeled 
tumour cells was added. Plates were centrifuged for 1 minute at 80 g on a Perkin Elmer centrifuge and 
incubated at 37 ºC for 60 minutes. After this, the medium of each well was removed and washed twice with 
200 μl RPMI1640/0.5% BSA medium. The remaining ﬂ uorescence per well was measured on a Perkin Elmer 
plate reader using 485 nm excitation and 530 nm emission ﬁ lters. On each plate a standard was prepared 
by adding different numbers of labeled tumour cells to the wells. The amount of tumour cells adhered was 
determined by calibrating the measured ﬂ uorescence of the experimental wells on the standard.
In order to determine the effect of ROS (in casu superoxide) on tumour cell adhesion, mesothelial monolayers 
were pre-incubated with Xanthine, Xanthine Oxidase and the combination of Xanthine and Xanthine Oxidase 
overnight. Medium from the experimental wells was removed and 200 μl RPMI1640/0.5%BSA containing 
30,000 calcein labeled tumour cells was added. Non pre-incubated mesothelial monolayers served as 
controls. The mesothelial cells were incubated with the Caco-2 cell according to the adhesion protocol 
described above.
Enzyme immuno-assay (EIA)
Enzyme immunoassay was used to determine the effect of X/XO on the expression of adhesion molecules. 
Mesothelial cells were grown to conﬂ uence in 96-well ﬂ at-bottomed multititer plates and pre-incubated 
with either cell culture medium alone or combined with X/XO overnight. Medium from the experimental 
wells was removed and the cells were ﬁ xed in 95% ethanol/ 5% methanol solution for 45 minutes. 
Subsequently, the cells were pre-incubated for 10 minutes with 1% normal goat serum, diluted in PBS, to 
inactivate unspeciﬁ c binding. Mouse anti-human monoclonal antibodies to ICAM-1 (CD54, R&D Systems), 
VCAM-1 (CD106, R&D Systems) and CD44H (CD106, R&D Systems) was added for 60 minutes. The 
cells were subsequently incubated with biotinylated goat antimouse antibody (Sigma-Aldrich Chemie, 
Zwijndrecht, the Netherlands) in a dilution of 1 : 500 for another 60 minutes. Finally the cells were 
incubated with a Streptavidin-peroxidase complex for 30 minutes, washed, and substrate (2,2’-azino-
bis(3-ethylbenthiazoline-6-sulfonic acid) in 0,05M phosphate-citrate buffer containing 0,03% sodium 
perborate was added. Incubation of the mesothelial cells without the primary antibody served as a 
negative control. After 40 minutes, the reaction was stopped using 0,4% sodium ﬂ uoride. Photometrical 
evaluation was performed with a computer-controlled ELISA-plate reader at λ = 405 nm.
Statistical analysis
All data were analyzed using analysis of variance (ANOVA) to determine overall differences between 
group means. If the ANOVA was signiﬁ cant on a 5% level, the post-hoc Newman-Keuls test was carried 
out to make a comparison between groups. P ≤ 0.05 was considered to be statistically signiﬁ cant. 
Experiments were carried out at least twice with comparable results.
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RESULTS
Validation of assay
Loading of the tumour cells with calcein did not affect their viability (>95% using trypan 
blue). To determine the stability of calcein uptake, the release of ﬂ uorescence in the 
supernatant of labeled cells after an incubation time of up to 120 minutes was measured. 
The ﬂ uorescence of the washed cells stayed constant for at least 90 minutes indicating 
retention of the dye in the cells (data not shown). A dilution series was made by using la-
beled Caco-2 cells on a mesothelial monolayer. There was a direct relationship between 
the cell number added and measured ﬂ uorescence resulting in a linear correlation which 
was used as a standard to calibrate the measured ﬂ uorescence. In this way the amount 
of adhered tumour cells in the experimental wells could be determined.
Tumour cell adhesion to a mesothelial monolayer
Tumour cell adhesion to a non pre-incubated mesothelial monolayer was relatively slow 
and temperature dependent. Maximum adhesion was seen after 60 minutes. At this time 
point a steady state situation was achieved and cell adhesion did not increase hereafter. 
The tumour cells remained rounded up during these adhesion assays. After more than 60 
minutes, the ﬁ rst signs of spreading out could be detected under the light microscope. 
Therefore, for all subsequent experiments, 60 minutes was taken as a cut-off point. 
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Figure 1
Adhesion of Caco-2 to a mesothelial monolayer after pre-incubation with PMN and FMLP stimulated 
PMN overnight. The adhesion of Caco-2 cells to mesothelial monolayers in the control situation is 
set to a 100% adhesion. Data are expressed as the mean (n=6) + SEM. *=p<0.05, **=p<0.01 vs 
control.
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Effect of PMN pre-incubation
Overnight incubation of a mesothelial monolayer with PMN in a transwell system did not 
modify total DNA content of the mesothelial monolayer and therefore did not affect cell 
growth (data not shown). 
The adhesion of the Caco-2 cells in the control situation was 23%. Pre-incubation of the 
mesothelial cells with unstimulated PMN resulted in an signiﬁ cant enhancement of adhe-
sion of the Caco-2 cells of 25% (p<0.05). FMLP stimulated PMN increased the adhesion 
of Caco-2 cells to the mesothelium with 40% (p<0.01) (ﬁ gure 1).
Ferricytochrome-C measurement
The assay is based on the turn over of ferric(Fe3+) iron to ferrous (Fe2+) iron, that can 
be measured at 550 nm. The turn over is a measure of the cumulative production of 
superoxide and is expressed as the optical density. The optical density was measured 
at intervals of 10 minutes over a period of 120 minutes. Xantine and xantine oxidase 
alone did not produce signiﬁ cant amounts of reactive oxygen species. However when 
combining xantine and xantine oxydase a marked increase in the optical density (ﬁ gure 
2) is seen. After an initial burst the superoxide production slowed down and almost no 
further superoxide production is seen after 120 minutes. 
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Figure 2
This ﬁ gure shows the results of the Ferricytochrome C reduction assay. It is a measure of the 
cumulative production of superoxide and is expressed as the optical density. Xanthine (X) and 
Xanthine Oxidase (XO) alone does not produce signiﬁ cant amounts of reactive oxygen species 
(ROS). Combined X/XO caused a signiﬁ cant enhancement of the optical density in the ﬁ rst 50 
minutes, denoting an signiﬁ cant burst of production of ROS.
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Effect of X/XO pre-incubation 
Adhesion of Caco-2 to non-stimulated mesothelial cells was 23%. Preliminary studies 
showed that at least 6 hours of pre-incubation were needed to induce enhanced cell ad-
hesion (data not shown). Maximum enhancement of tumour cell adhesion was achieved 
after 12 hours of pre-incubation with X/XO (70% enhancement compared to the control 
situation, p<0.01) (ﬁ gure 3). With light microscopy, marked morphologic changes were 
seen in cell appearance of the monolayer after 24 hours. After 12 hours pre-incubation, 
stretching of cells could be observed, but the monolayer was still intact. 
Expression of cell adhesion molecules
EIA is a semiquantitative assay investigating the dynamics of expression of adhesion 
molecules on mesothelial cells or tumour cells with or without stimulating the cells with 
X/XO (in optical density units measured at 405 nm). The staining intensity for ICAM-1 of 
unstimulated mesothelial cells was 0.285, whereas the negative control gave an intensity 
of 0.118, indicating a marked basal expression of ICAM-1 on mesothelial cells. Opti-
cal density for VCAM-1 and CD44H was 0.137 and 0.184 respectively, indicating 
that mesothelial cells have a basal expression of VCAM-1 and CD44H as well. When 
stimulating the mesothelial cells with X/XO for 12 hours, which is the optimal time point 
for adhesion of Caco-2 to mesothelial cells, a signiﬁ cant (p<0.01 vs control) increase in 
expression of ICAM-1, VCAM-1 and CD44H could be observed (ﬁ gure 4).
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Figure 3
Adhesion of Caco-2 to a mesothelial monolayer after pre-incubation with X, XO and X/XO overnight. 
The adhesion of Caco-2 cells to mesothelial monolayers in the control situation is set to a 100% 
adhesion. Data are expressed as the mean (n=6) + SEM. *=p<0.05, **=p<0.01 vs control.
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DISCUSSION
Surgical treatment of patients with gastro intestinal cancer is complicated by high recur-
rence rates. In case of colorectal carcinoma more than 40% of patients, who undergo 
potentially curative resection of advanced colorectal cancer, do develop recurrence of 
the disease. Peroperatively spilled tumour cells or circulating tumour cells apparently 
proﬁ t from the inﬂ ammatory sequelae provoked by surgery, ultimately leading to manifest 
tumour recurrence 1.
The direct effects of surgery lead to damage to the mesothelial lining of the abdominal 
cavity. This causes a cascade of events, commonly termed the sterile inﬂ ammatory re-
sponse after surgery.23,24 During this response, inﬂ ammatory cells, like macrophages, 
monocytes and polymorph nuclear leukocytes (PMN), are attracted to the site of injury 
and inﬂ ammation.25 This attraction takes place through the release of chemo attractants 
(e.g. IL-8) and transsection of blood vessels.
Macrophages, monocytes and also mesothelial cells are known to produce cytokines, 
providing mutual interaction. IL-1β and TNF-α have been shown to induce activation of 
transcription factors like NF-κB and AP-1, leading to an augmentation of both the in-
ﬂ ammatory response and tissue damage.26 Cytokine-activated mesothelial cells produce 
chemo-attractants, like IL-8, leading to recruitment of PMN. In this way, the mesothelium 
and inﬂ ammatory cells in the abdominal cavity may perpetuate a cytokine loop, resulting 
in extreme activation of the inﬂ ammatory process. In addition, cytokines (like IL-1β and 
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Figure 4
Expression of adhesion molecules, ICAM-1, CD44 and VCAM-1 on mesothelial cells and stimulated 
mesothelial cells with X/XO overnight. *=p< 0.01 vs. control.
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TNF-α) have been shown to upregulate adhesion molecules on mesothelial cells and in 
that way enhanced tumour cell adhesion.27 
In previous studies we provide evidence that passive transfer of lavage ﬂ uid, collected 
after inﬂ icting surgical trauma, can lead to enhanced tumour recurrence in naïve recipi-
ents. The cellular component of the lavage ﬂ uid gave rise to the greatest enhancement 
of tumour recurrence (van Rossen et al. unpublished). Detailed analysis of this cellular 
fraction revealed a trauma related inﬂ ux of PMN into the abdominal cavity. There is a 
correlation between the amount of surgical trauma and an enlarging shift of primarily 
monocytes to PMN in the lavage ﬂ uid. This phenomenon will evidently affect the homeo-
static milieu of the peritoneum. These PMN seem to play a pivotal role in the enhanced 
tumour recurrence seen after surgical trauma.
The oxygen-dependent and oxygen-independent processes of the PMN participate in the 
killing of bacteria, but those same processes can also result in damage to host tissue. Es-
pecially in ischemia and reperfusion injury research, evidence became available about 
the damage ROS can inﬂ ict on transplanted organs, leading to possible decreased 
graft function. ROS, like superoxide can inﬂ ict damage to mesothelial surfaces by induc-
ing adenine nucleotide depletion28, membrane damage29 and DNA damage.30 ROS 
can, besides their well known direct toxic effects, also function as signal transduction 
molecules to activate the chemotactic cytokine interleukin-8 (IL-8) and the transcription 
factors NF-κB and AP-1, resulting in upregulation of the cell surface adhesion protein, 
intercellular adhesion molecule-1 (ICAM-1).31 Together, IL-8 and ICAM-1 orchestrate the 
transendothelial migration of PMN to sites of inﬂ ammation and injury. So, there seems 
to be a positive feedback in which PMN, through the production of ROS, stimulate the 
inﬂ ux of even more PMN.
Yokoyama reported that massive quantities of Xanthine Oxidase (XO) are released into 
the circulation after hepatic ischemia-reperfusion injury.32 These products can serve as a 
potential source of circulating oxygen radical production, resulting in tissue injury at sites 
distal to its origin. Therefore the hypothesis of this study was that ROS produced by PMN 
after surgical trauma inﬂ uence the adhesion of tumour cells to mesothelial monolayers.
This study demonstrate the enhancement of adhesion of colon carcinoma cells on meso-
thelium after pre-incubation of the mesothelium with PMN. By means of the superoxide 
production measurement assay, we demonstrated that PMN do produce ROS. Because 
isolation of PMN from whole-blood might possibly stimulate the PMN in a non-physiologi-
cal way, we used the ROS producing combination of X and XO in our in vitro experiments 
to mimic the inﬂ uence of ROS produced by PMN. Mesothelial cells have the disposal 
of endogenous amounts of X and XO. When incubated with exogenous XO, they were 
able to generate superoxide in small amounts. This amount of superoxide proved to be 
sufﬁ cient to induce a moderate increase in tumour cell adhesion to mesothelial monolay-
ers. The amount of endogenous XO was too low to generate superoxide in the presence 
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of exogenous X. In the mesothelial experiment the combination of X and XO, releasing 
superoxide in larger quantities, resulted in the highest increase of tumour cell adhesion. 
This outcome might be explained by an upregulation of the adhesion molecules, ICAM-
1, VCAM-1 and CD44, on the mesothelial cells according to the results of the enzyme 
immunoassay.
In conclusion, this study demonstrated that PMN produce ROS and that incubation of 
mesothelial cells with activated PMN increased colon carcinoma adhesion. This effect 
is likely mediated via the ROS produced by PMN, since incubation of the mesothelial 
monolayers with ROS increased tumour cell adhesion. The results give evidence that the 
inﬂ ammatory response, i.c. PMN inﬂ ux after surgery promote tumour recurrence. Prevent-
ing tissue damage by inﬂ ammatory cells therefore may provide a novel strategy to defeat 
progression and metastasis of cancer. Manipulation of the intricate cytokine network 
may cause unwanted side effects in the wound healing process. Attacking of the reactive 
oxygen products or blocking the adhesion molecules however seems a feasible way of 
preventing cellular tissue damage ultimately resulting in diminished tumour recurrence.
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ABSTRACT
Postoperative peritoneal carcinomatosis is a signiﬁ cant clinical problem after curative 
resection of pancreatic carcinoma. Peroperative surgical trauma activates a cascade 
of peritoneal defence mechanisms responsible for postoperative intra-abdominal tumour 
recurrence. Reactive oxygen species (ROS) play a pivotal role in this postoperative in-
ﬂ ammatory reaction. This study explores the inﬂ uence of ROS on adhesion of human 
pancreatic carcinoma cells to human mesothelial cells. Furthermore this study explores 
the inﬂ uence of ROS on the presentation of adhesion molecules on Panc-1 and meso-
thelial cells. ROS were produced using the enzymatic reaction of xanthine with xanthine 
oxidase (X/XO). 
Mesothelial monolayers were incubated with ROS produced prior to adhesion of the 
tumour cells. Incubation of the mesothelial cells with X/XO resulted in a signiﬁ cant in-
crease (69.5%) in adhesion of Panc-1 in all patients. SOD/catalase, anti-oxidants, could 
reduce this increase by 56.7%. ROS signiﬁ cantly inﬂ uenced the expression of the adhe-
sion molecules ICAM-1, VCAM-1 and CD44 on mesothelial cells, but did not inﬂ uence 
adhesion molecule expression on Panc-1. 
The ROS released during the post-operative inﬂ ammatory reaction may play an important 
role in the adhesion of pancreatic tumour cells to the mesothelium. Possibly by inﬂ uencing 
adhesion molecule expression on mesothelial cells. Therefore ROS can partly be respon-
sible for the enhanced post-operative intra-abdominal tumour recurrence.
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INTRODUCTION
Pancreatic carcinoma has the lowest 5-year survival rate of any cancer. Surgical resec-
tion is the only chance for cure, but the overall 5-year survival is only 6.8 – 25%, and 
up to 50% of those who survive 5 years may die of recurrent cancer.1 In 70-80% local 
recurrence and/or peritoneal dissemination is found after potentially curative resection 
of pancreatic carcinoma. 
Early preoperative tumour cell seeding and peroperative intra-abdominal shedding of 
tumour cells, due to handling the tumour and leakage from dissected lymphatic channels, 
are the most likely causes of peritoneal carcinosis.2, 3 Previous experimental data have 
demonstrated that the proliferative and metastatic potentials of these spilled tumour cells 
are very well preserved.4 Peroperative occurrence of tumour cells in the peritoneal cavity 
has been shown to negatively correlate with the postoperative survival rate.4, 5 Previously 
described clinical and experimental studies showed that surgical trauma promotes intra-
abdominal tumour recurrence.6-8 In an animal experimental study Raa et al.9 showed 
that this effect is mainly due to enhanced adhesion of tumour cells rather than enhanced 
growth of already adhered tumour cell clusters. 
The dynamic cascade of peritoneal healing, induced by peritoneal damage, seems 
to be important in the process of intra-peritoneal adhesion of tumour cells.8, 10, 11 We 
demonstrated earlier that within a few hours after inﬂ iction of peritoneal trauma, fac-
tors in the abdominal cavity could be captivated in a lavage ﬂ uid enhancing tumour 
recurrence in naive, non-operated recipients.8 Separated components of these lavage 
ﬂ uids i.e. inﬂ ammatory cells and soluble factors, could each enhance tumour recurrence, 
however the cellular fraction led to the greatest tumour load. More detailed analysis of 
the cellular fraction revealed a peritoneal trauma related inﬂ ux of polymorph nuclear 
leucocytes (PMN) in the abdominal cavity. Similar shifts in cell differentiation following 
peritoneal trauma have been demonstrated in other animal models.12-14 The exact role 
of PMN in post-surgical enhanced tumour development is not yet clear. In the early post-
operative inﬂ ammatory reaction PMN are responsible for clearing dead tissue and invad-
ing organisms by producing and releasing reactive oxygen species (ROS). Especially 
oxygen-free radicals and hydrogen peroxide are formed. Despite this beneﬁ cial effect, 
the overwhelming oxidative potential can result in additional tissue destruction.15, 16 Van 
Rossen et al.17 showed in an animal model that inhibition of ROS with the use of the anti-
oxidant enzymes superoxide dismutase (SOD) and catalase lead to diminished tumour 
recurrence. The exact effect of ROS on the peritoneum is unknown. Whether the effects 
shown by van Rossen et al. is fully explained by reducing additional tissue damage by 
ROS, or whether ROS also have a direct effect on the mesothelial cells remains unclear. 
The aim of the current in-vitro study was to evaluate the effect of ROS on pancreatic 
tumour cell adhesion to a monolayer of human mesothelial cells. And whether anti-oxi-
dants could be used to reduce post-operative enhanced tumour adhesion. Moreover we 
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analyse the effects of ROS by assessing the expression of adhesion molecules on both 
mesothelial cells and tumour cells. To produce ROS, the reaction of xanthine with xan-
thine oxidase was used that is known to produce superoxide and hydrogen peroxide.18
MATERIALS AND METHODS
Culture and identification of omental mesothelial cells
Mesothelial cells (MC) were obtained from the human omental tissue. The experimental protocol was 
approved by the Medical Ethical Committee of the Erasmus Medical Centre Rotterdam, The Netherlands. 
The MC were isolated according to techniques modiﬁ ed from Nicholson et al.19 and Wu et al.20. The 
omentum was transferred to ﬂ uid containing 0.05% trypsin-0.02% EDTA (Invitrogen, Karlsruhe, Germany). 
After 15 minutes the detached MC were pelleted by centrifugation at 1800 rpm for 10 minutes and were 
resuspended in RPMI 1640 supplemented with 10% fetal calf serum, L-glutamin (2 mmol/L) and penicillin 
(105 U/ml) (Invitrogen, Karlsruhe, Germany). MC were grown until conﬂ uence in a 37ºC, fully humidiﬁ ed, 
5% CO2 cabinet in polystyrene culture ﬂ asks (75 cm
2, Corning BV, Schiphol-Rijk, The Netherlands) pre-
coated with collagen type I (17.5 μg/ cm2 ). The identity of MC was demonstrated by the absence of 
Von Willebrand factor staining 21 and the presence of intracellular cytokeratins 22 via immunohistological 
staining with monoclonal antibodies (Dako, Amsterdam, The Netherlands).
Panc-1 cell line
The human pancreas carcinoma cell line Panc-1 was grown in RPMI 1640 medium supplemented 
with 10% fetal calf serum, glutamin (2mM) and penicillin (105 U/L) and maintained by serial passage 
after trypsinization using 0.05% trypsin/ 0.02% EDTA. Before the adhesion assay, tumour cells were 
trypsinized and maintained in suspension culture for 2 hrs to regenerate cell-surface proteins.
Drugs
The cell cultures were exposed to the reactive oxygen species (ROS) superoxide and hydrogen peroxide 
generated by xanthine oxidase (0.05 U/ml, Sigma-Aldrich Chemie, Zwijndrecht, the Netherlands) upon 
the addition of xanthine (0.1 mmol/l, Sigma-Aldrich Chemie, Zwijndrecht, the Netherlands) (X/XO). The 
oxygen-free radicals are produced by the following enzymatic reaction: xanthine + O2 + H2O  Uric acid 
+ H2O2 + O2
-, catalyzed by xanthine oxidase.
The anti-oxidant enzymes SOD (5000 U/mg) from Roche Diagnostics BV, Almere, the Netherlands and 
catalase (2350 U/mg) from Sigma-Aldrich Chemie BV, Zwijndrecht, the Netherlands were added to 
the cell cultures in a 400U/ml and 200U/ml ﬁ nal concentration, respectively, to counteract the ROS 
production speciﬁ cally.
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Ferricytochrome c reduction
Superoxide generation by xanthine/xanthine oxidase (X/XO) was determined using the ferricytochrome c 
(cytc) reduction assay modiﬁ ed from Leslie et al.23 In brief, cytc was prepared in HBSS without phenol red 
and used at a ﬁ nal concentration of 150μM. After ﬁ lling each well with 100 μl of cytc, cytc + xanthine 
or cytc + xanthine + SOD/catalase , the reaction was started by adding 100 μl of xanthine oxidase 
solution (100 μl/well). Wells ﬁ lled with cytc in HBSS served as a blank. The plate was kept at a constant 
temperature of 37ºC using a thermostatted microplate reader (Versamax, Molecular Devices), and read 
every 10 minutes up to 120 minutes. The amount of reduced cytc reduction was calculated from the 
absorbance at 550 nm with 540 nm as the reference using molar absorbance coefﬁ cient of 12.2 x 103 
M-1.23 
Apoptosis assay
To examine if overnight incubation of the mesothelial monolayer with X/XO could induce apoptosis, a 
cell death detection ELISA-kit (Roche Diagnostics BV, Almere, the Netherlands), was used based on a 
quantitative sandwich-enzyme-immunoassay with mouse monoclonal antibodies directed against human 
DNA and histones, respectively. This allows the speciﬁ c determination of mono- and oligonucleosomes in 
the cytoplasmatic fraction of cell lysates.
Adhesion assay
To quantify tumour cell adhesion to mesothelium, a previously standardized and validated cell adhesion 
assay was used.24 In short, mesothelial cells were transferred to 96-well plates (Perkin Elmer, Groningen, 
the Netherlands) pre-coated with collagen type-1 and grown to conﬂ uency as conﬁ rmed by light 
microscopy. In order to determine the effect of ROS on tumour cell adhesion, mesothelial monolayers or 
Panc-1 were pre-incubated with X/XO for 12 hours. Untreated cells served as a control.
Tumour cells were labelled with calcein-AM (Molecular Probes, Leiden, NL) by incubating 1 x 106 
Panc-1 cells/ml RPMI medium with 1% FCS containing 10 μM calcein-AM for 45 minutes at 37 °C with 
occasional mixing. After washing the labeled Panc-1 twice with RPMI containing 1% FCS to remove free 
dye, supernatant from the experimental wells was removed and 30.000 labelled Panc-1 cells in 200 μl 
RPMI/1% FCS were added. Plates were centrifuged for 1 minute at 80 g and incubated at 37 °C for 
one hour. After washing away unbound cells, the numbers of adherent tumour cells were assessed by 
measuring ﬂ uorescence at 485 nm excitation and 535 nm emission using a standard curve prepared 
from various numbers of labelled tumour cells.
Enzyme immuno-assay (EIA) of cellular adhesion molecules
A previously described enzyme immunoassay was used to determine the effect of X/XO on the expression 
of adhesion molecules. Mesothelial cells and Panc-1 were grown to conﬂ uence in 96-well ﬂ at-bottomed 
multititer plates and pre-incubated with either cell culture medium alone or in combination with X/XO 
or X/XO and SOD/catalase for 12 hours. Medium from the experimental wells was removed and the 
cells were ﬁ xed in 95% ethanol/ 5% methanol solution for 45 minutes. Subsequently, the cells were 
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pre-incubated for 10 minutes with 1% normal goat serum, diluted in PBS, to block non-speciﬁ c binding. 
Mouse anti-human monoclonal antibodies to ICAM-1 (CD54, R&D Systems; diluted 1 : 500), VCAM-1 
(CD106, R&D Systems; diluted 1 : 500), LFA-1 (CD11a, Leinco Technologies; diluted 1 : 10), VLA-4 
(CD49d, R&D Systems; diluted 1 : 50), CD44 (CD106, R&D Systems; diluted 1 : 500) were added for 
60 minutes. Tumour cells or mesothelial cells incubated without one of these primary antibody served as 
a negative control. After a washing step with phosphate buffered saline (room temperature, pH 7.4) the 
cells were subsequently incubated with biotinylated goat antimouse antibody (Sigma-Aldrich Chemie, 
Zwijndrecht, the Netherlands) in a dilution of 1 : 500 for another 60 minutes. Finally the cells were 
washed with phosphate buffered saline and incubated with a streptavidin-peroxidase complex for 30 
minutes, washed, and substrate (2,2’-azino-bis(3-ethylbenthiazoline-6-sulfonic acid) in 0.05M phosphate-
citrate buffer containing 0.03% sodium perborate was added. After 40 minutes, the reaction was stopped 
using 0.4% sodium ﬂ uoride and the absorbance was read at 405 nm. Membrane antigen expression is 
expressed as OD units. 
Statistical analysis
All data were analyzed using analysis of variance (ANOVA) to determine overall differences between 
group means. If the ANOVA was signiﬁ cant on a 5% level, the post-hoc Newman-Keuls test was carried 
out to make a comparison between groups. P ≤ 0.05 was considered to be statistically signiﬁ cant. 
Experiments were carried out at least twice with comparable results.
RESULTS
Quantification of ROS generation by xanthine/xanthine oxidase
To appreciate the effect of the xanthine/xanthine oxidase (X/XO) system on the adhesion 
of Panc-1 cells to mesothelial monolayers, the amount of ROS produced by X/XO was 
determined over time. The results showed that X and XO alone did not produce signiﬁ cant 
amounts of ROS. However when combining X and XO, superoxide was produced at a 
rate of 0.4097 nmol/ml/min during the observation period of 60 min (ﬁ gure 1). After 
that the amount of superoxide did not increase much showing that the rate of superoxide 
production approached zero. In the presence of SOD, the superoxide generated by 
X/XO was almost completely inactivated (ﬁ gure 1).
Effect of ROS on mesothelial cell viability
Inspection by light microscopy showed that up to 12 hours of incubation with X/XO, 
the monolayer was still intact, but marked morphologic changes in cell appearance of 
the monolayer occurred after 24 hours. Simultaneous adding of SOD and catalase with 
X/XO prevented this effect of X/XO.
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Further study showed that a signiﬁ cant number of the mesothelial cells already became 
apoptotic when incubated with X/XO for 12 hours (ﬁ gure 2). XO only induced some 
apoptosis, while X alone had no effect (ﬁ gure 2). Addition of SOD/catalase inhibited 
the apoptosis-inducing effect of X/XO almost completely.
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Figure 1
Ferricytochrome C reduction assay. Superoxide production by control (- g -), X (-p-), XO (-q-), X/XO (-Æ-) 
or X/XO and SOD/catalase (-®-). Cumulative superoxide production is displayed nmol/ml ± SEM 
(n=6/condition).
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Figure 2
Apoptosis assay. * = p < 0.05 vs. control, ** = p < 0.001 vs. control.
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Effect of ROS on Panc-1 adherence
Tumour cell adhesion to non-stimulated mesothelial monolayers reached a maximum after 
60 minutes. The mean adhesion of Panc-1 cells in the control situation was 21%. After 
incubation of the mesothelial monolayer with X/XO, the number of adhering Panc-1 cells 
did not differ from the control up to 6 hr, but increased to 61% stimulation (SD = 14%); 
p < 0.001) after 12 hours of pre-incubation with X/XO (ﬁ gure 3). If SOD and catalase 
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Figure 3
Adhesion of Panc-1 to a mesothelial monolayer after pre-incubation with X/XO at varying time 
intervals. Data are expressed as the mean (n=6) and SEM.
* = p < 0.05; ** = p < 0.001.
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Figure 4
Adhesion of Panc-1 to a mesothelial monolayer after pre-incubation with X/XO with or without SOD/
catalase. Data are expressed as the mean (n=6) and SEM. ** = p < 0.001; # = p < 0.05.
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were added during pre-incubation of the mesothelial monolayer with X/XO, the stimula-
tory effect of ROS on the adherence of Panc-1 cells to the mesothelial cells could be 
inhibited almost completely (ﬁ gure 4), while pre-incubation of the mesothelium with SOD 
and catalase alone did not affect tumour cell adhesion. Incubation of Panc-1 with X/XO 
did not affect adhesion of the tumour cells to the mesothelial monolayer.
Expression of cell adhesion molecules
To investigate if an increased expression of cellular adhesion molecules by the meso-
thelium underlies the increase in adherence of Panc-1 cells to ROS-treated mesothelial 
cells, the expression of various adhesion molecules was studied. The results showed that 
normal mesothelial cells express ICAM-1 (141% above the negative control), while the 
expression of CD44 and VCAM-1 was low (16%) and moderate (56%) (ﬁ gure 5). When 
stimulating the mesothelial cells with X/XO for 12 hours, after which the adhesion of 
Panc-1 to mesothelial cells was maximal, a signiﬁ cant increase in expression of ICAM-1, 
VCAM-1 and CD44 could be observed (ﬁ gure 5). Adding SOD and catalase to X/XO 
prevented the increase in expression of these adhesion molecules. Mesothelial cells did 
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Figure 5
Expression of adhesion molecules on mesothelial cells stimulated with X/XO with or without SOD and 
catalase. Optical density represents the median absorbance values and range at 405 nm. * = p < 
0.001 vs. control.
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not express the adhesion molecules VLA-4 and LFA-1 and this pattern did not change 
upon stimulation with X/XO (ﬁ gure 5). 
Panc-1 cells express the adhesion molecules CD44 (89% above neg. control), ICAM-1 
(77%) and only low levels of VLA-4 (20%) (ﬁ gure 6). Panc-1 does not express LFA-1. The 
expression levels of these adhesion molecules did not change upon stimulation by X/XO 
(results not shown).
DISCUSSION
For local or peritoneal tumour recurrence to develop, adhesion and growth of per-operatively 
spilled tumour cells is necessary. Cytokines and growth factors produced in great amount 
after surgical trauma, are known to promote tumour recurrence in in vivo and in vitro animal 
models.8, 11, 25 
The present study demonstrates that ROS stimulate tumour cell adhesion to the peritoneum 
in a human in vitro model. The mechanism by which ROS are able to enhance tumour cell 
adhesion is dual. Firstly, we found that ROS are able to directly damage the peritoneal lining 
(through induction of apoptosis of mesothelial cells). The subsequent exposing of the ECM will 
create a preferential adhesion site for the tumour cells.26 Under the present conditions, how-
ever, the mesothelial monolayer was still intact as examined by phase-contrast microscopy 
after 12 hr of stimulation by ROS. 
Another mechanism by which ROS could stimulate tumour cell adhesion is by enhancing the 
expression of adhesion molecules, either on mesothelial cells or pancreatic carcinoma cells. 
The expression of adhesion molecules on human mesothelial cells under the inﬂ uence of 
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Figure 6
Expression of adhesion molecules on Panc-1. * = p < 0.01 vs. negative control. No changes were 
seen upon stimulation with X/XO. Optical density represents the median absorbance values and 
range at 405 nm.
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inﬂ ammatory cytokines (TNFα, IL-1β, IL-8) has been analysed. Generally these studies show 
an increase in ICAM-1, VCAM-1 and CD44 upon stimulation with different pro-inﬂ ammatory 
cytokines.27-29 
In the present study we found that ROS induced the expression of adhesion molecules VCAM-
1, ICAM-1 and CD44 on mesothelial cells as well. ROS did not alter the expression pattern 
of adhesion molecules on the Panc-1 cell membrane and therefore the observed increase in 
Panc-1 tumour cell adhesion to the mesothelial cells is dependent on changes of the mesothe-
lium. Hosono et al.30 showed that CD44 plays an essential role in the initial attachment of 
pancreas carcinoma cell-line (SW1990) to mesothelial cells and Ziprin et al.29 demonstrated 
that ICAM-1 blockade reduced the ability of pancreas carcinoma cell line PSN-1 to adhere 
to the mesothelium. These results are supported by ﬁ ndings of van Grevenstein et al.28 who 
demonstrated the effect of inﬂ ammatory cytokines (TNFα, IL-1β and IL-8) on adhesion of 
pancreatic carcinoma cell lines (MiaPaCa-2 and BxPc3) to mesothelial cells. Surprisingly, no 
effects of these cytokines were seen on adhesion of Panc-1 to a monolayer of mesothelial 
cells in their study. They already discussed the problem of high basal adhesion of Panc-1, 
which was not seen in the present study. Moreover, no expression of VLA-4 was found 
on Panc-1 by classical immunohistochemical staining. However, the more sensitive enzyme 
immunoassay did show expression of VLA-4 on mesothelial cells. Possibly the tripsinisation 
step used in their experiments inﬂ uenced the expression of VLA-4. Important is that VLA-4 is 
the counterpart of VCAM-1 which has shown to be upregulated in mesothelial cells upon 
stimulation with ROS and inﬂ ammatory cytokines. Therefore VCAM-1 might play an important 
role in the adhesion of Panc-1 to mesothelial monolayers. In the present study ICAM-1 might 
be of less importance, as the mesothelial cells as well as Panc-1 did not express its natural 
ligand LFA-1. Although Ziprin et al.27 showed CD43 as an important ligand for ICAM-1 
and mediator in adhesion of pancreas carcinoma as well as colon carcinoma cell-lines to 
mesothelial cells.
Taking the expression patterns of most pancreas carcinoma cell-lines into account, adhesion 
to mesothelial cells have shown to be inﬂ uenced by the adhesion molecules ICAM-1, VCAM-
1 or CD44. ROS upregulate the expression of these adhesion molecules on mesothelial cells 
and have shown to enhance adhesion of Panc-1 to mesothelial cells. It is very well conceiv-
able that ROS will enhance adhesion of other pancreas carcinoma cell-lines as well, although 
this was not investigated in the present study.
In conclusion, despite this emerging complex picture, the present study indicated that ROS 
released during the post-operative inﬂ ammatory reaction could play an important part in the 
adhesion of pancreatic carcinoma cells to the mesothelium. Although in this study only Panc-1 
carcinoma cells were used and general statements are therefore premature, these ﬁ ndings 
may indicate a rationale for using anti-oxidants as a treatment modality to prevent/reduce 
activation of the mesothelium and subsequent tumour recurrence after surgical trauma.
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ABSTRACT
The inﬂ ammatory response followed by abdominal surgery induces the production of 
active mediators in the abdominal cavity. Beside the inﬂ uence of these local produced 
factors on local tumour recurrence, we hypothesize that during surgery systemically 
produced mediators are potential stimulators of tumour cell adhesion as well. The aim 
of this study was to investigate the inﬂ uence of serum samples, obtained at 8 different 
time periods before, during and after surgery on the interaction between human colon 
carcinoma cells and mesothelial cells.
In the control situation the average adhesion of the Caco2 cells to the mesothelial 
monolayers was 29%. No enhancement in adhesion was observed after incubation of 
the mesothelial cells with the pre- or post-operative serum of the patients.
This study suggests that systemic factors produced directly after surgery are not inﬂ uenc-
ing tumour adhesion to mesothelial monolayers. Therefore, local tumour recurrence is 
probably only inﬂ uenced by locally produced factors. 
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INTRODUCTION
Local tumour recurrence after curative surgery of colorectal tumours is a persistent prob-
lem. The local recurrence rate is almost 50 per cent after curative resection. The most 
common sites of local recurrence are the site of the primary tumour and the peritoneal 
surface.1 There are several theories on the mechanism of local recurrence of spilled 
tumour cells. According to the theory of metastatic efﬁ ciency, implantation of tumour 
cells onto raw tissue surfaces is an efﬁ cient process compared to inefﬁ cient implan-
tation.1 The ﬁ brin entrapment hypothesis proposes that peroperatively spilled tumour 
cells are trapped in ﬁ brin at the resection site and on damaged peritoneal surfaces.2 
Another hypothesis on which our study is based, suggests that after surgical trauma 
the acute inﬂ ammatory response will produce a great amount of growth factors and 
cytokines which are very beneﬁ cial for the healing process, but also for adhesion and 
growth of tumour cells.3-7 Surgical handling of the peritoneum is ambiguous regarding 
cancer. In case of massive tissue damage, the ensuing inﬂ ammatory reaction produces 
a potentially lethal cocktail of active mediators. These mediators are known to inﬂ uence 
tumour recurrence to the peritoneum, probably caused by an upregulation of adhesion 
molecules, like ICAM-1 and VCAM-1. Besides these locally produced cytokines and 
adhesion molecules, systemically produced mediators might be potential stimulators 
of local tumour cell adhesion as well. Recently, a soluble form of ICAM-1 has been 
described and elevated levels have been associated with advance disease in gastric, 
colon, gallbladder, pancreatic and renal carcinomas.8 Pre-operative serum levels of 
ICAM-1, E-selectin and VCAM-1 are also correlated in gastric and colorectal cancer 
with invasion, lymph node involvement and distant mestastasis.9,10 Serum levels of these 
adhesion molecules, measured at day 7, decreased signiﬁ cantly after radical resection 
of the tumour compared with pre-operative levels. The serum levels of these adhesion 
molecules remain unchanged in patients with unresectable tumours and in patients who 
underwent surgery for benign gastric disease.10
We hypothesized that during surgery, systemically produced mediators might be poten-
tial stimulators of local tumour recurrence. Therefore, in the present study we investigated 
the inﬂ uence of serum, obtained at 8 different time periods before, during, and after 
surgery from patients who underwent elective abdominal surgery for colorectal carci-
noma, on the interaction between colon carcinoma cells and mesothelial cells. We 
developed an in vitro model, in which we studied the adhesion of colon carcinoma cells 
on mesothelial cells pre-incubated with serum from the same patient.
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MATERIALS AND METHODS
Serum samples of patients, culture of omental mesothelial cells and cell line
In total, we studied 9 patients undergoing elective abdominal surgery who had given informed consent 
to donate 8 samples of blood at 8 different time points and to donate a piece of omental tissue during 
surgery. The experimental protocol was approved by the Medical Ethical Committee of the Erasmus 
Medical Center Rotterdam, The Netherlands.
Blood was drawn one day before surgery, time point -24, at the beginning of the operation, time point 
0, and 2, 4, 8, 12, 24 and 48 hours after surgery. One sample of blood was taken at every time 
point. From each sample we obtained approximately 4 ml of serum.
Mesothelial cells (MC) were obtained from the omental tissue of the same patients. The MC were 
isolated according to techniques modiﬁ ed from Nicholson et al.11 and Wu et al.12 and cultured in 
RPMI1640 medium supplemented with 10% human pooled normal serum, L-glutamin (200 mmol/L) and 
penicillin (5000 U/ml). 
The human colon adenocarcinoma cell line Caco-2 was a kind gift of Dr. W. Dinjens (Department 
of Pathology, Erasmus Medical Center Rotterdam, The Netherlands). The cell line was cultured in 
RPMI1640 medium supplemented with 10% human pooled serum, L-glutamin (200 mmol/L) and 
penicillin (5000 U/ml). All supplements were obtained from Invitrogen (Karlsruhe, Germany). For 
experiments, the cells were trypsinized (5 minutes at 37ºC), centrifuged (5 minutes at 450 g), 
resuspended in RPMI 1640 and counted. Viability was measured by trypan blue exclusion and always 
exceeded 95 percent.
Adhesion assay
To quantify tumour cell adhesion to a monolayer mesothelium, a standardised cell adhesion assay was 
developed according to methods from Catterall et al.13 Mesothelial monolayers were established in 
96 well plates (Canberra Packerd, Groningen, The Netherlands), pre-coated with collagen type I (15 
μg/cm2, coating according to instructions of the manufacturer). To do this, conﬂ uent cells were washed 
with phosphate buffered saline (PBS) and harvested with trypsin (0.05%) and EDTA (0.02%) and 2.5 
x 104 mesothelial cells were added in 200 μl of medium to each well. The plates were incubated 
at 37 ºC, in a humidiﬁ ed atmosphere of 5% CO2 in air; medium was replaced daily with fresh 
medium. Monolayers reached conﬂ uence in 5 to 7 days as determined by light microscopy. In order 
to determine the effect of the serum samples on tumour cell adhesion, mesothelial monolayers were 
pre-incubated overnight with the 8 serum samples of the same patient. We used a 10% serum-RPMI 
medium. The control mesothelial monolayers were incubated overnight in medium with 10% human 
pooled normal serum.
Tumour cells were labelled with calcein. Before adding to the mesothelial monolayers, the labelled cells 
were washed twice with RPMI1640/0.5%BSA to remove free dye. Medium from the experimental 
wells was removed and 200 μl RPMI1640/0.5%BSA containing 30,000 calcein labelled tumour cells 
was added. Plates were centrifuged for 1 minute at 80 g on a Perkin Elmer centrifuge and incubated 
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at 37 ºC for 60 minutes. Thereafter, the medium of each well was removed and washed twice with 
200 μl RPMI1640/0.5% BSA medium. The remaining ﬂ uorescence per well was measured on a Perkin 
Elmer plate reader using 485 excitation and 530 emission ﬁ lters. On each plate, a standard was 
prepared by adding different numbers of labelled tumour cells to the wells. The amount of tumour cells 
adhered was determined by calibrating the measured ﬂ uorescence of the experimental wells on the 
standard.
Statistical analysis
All data were analysed using analysis of variance (ANOVA) to determine overall differences between 
group means. If the ANOVA was signiﬁ cant on a 5% level, the post-hoc Newman-Keuls test was carried 
out to make a comparison between groups. Values represent ± SEM of n=6 wells per treatment. P≤ 
0.05 was considered to be statistically signiﬁ cant. 
RESULTS
During the ﬁ rst day of culture, the mesothelial cells spread out to make contact to each 
other in order to create a monolayer (ﬁ gure 1A). After 3-5 days, a monolayer is formed 
with a typical cobblestone appearance (ﬁ gure 1B). The morphology of the monolayers 
did not change after pre-incubation with the serum samples. 
Loading of the tumour cells with calcein did not affect their viability (>95% using trypan 
blue). To determine the stability of calcein uptake, the release of ﬂ uorescence in the super-
natant of labelled cells after an incubation time of up to 120 minutes was measured. The 
ﬂ uorescence of the washed cells remained constant for at least 90 minutes, indicating 
BA
Figure 1
Growth features of mesothelial cells. During the ﬁ rst days of culture, the mesothelial cells spread 
out to make contact to each other in order to form a monolayer (1A). After 3-5 days there is a 
monolayer, notice the typical cobblestone appearance (1B).
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retention of the dye in the cells (data not shown). A dilution series was made by using la-
belled Caco2 cells on a mesothelial monolayer. There was a direct relationship between 
the cell number added and measured ﬂ uorescence, resulting in a linear correlation which 
was used as a standard to calibrate the measured ﬂ uorescence. In this way the number 
of adhered tumour cells in the experimental wells could be determined.
Tumour cell adhesion to a mesothelial monolayer in medium with 10% human pooled se-
rum was relatively slow and temperature dependent. Maximum adhesion was seen after 
60 minutes. At this time point a steady state situation was achieved and cell adhesion 
did not increase hereafter. The tumour cells remained rounded up during these adhesion 
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Figure 2
Bargrafts showing the adhesion of Caco-2 cells to monolayers mesothelium of 9 different patients 
pre-incubated with serum samples of the same patient at 8 different periods. Data are expressed as 
the mean (n=8) +SEM. 
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assays. After more than 60 minutes, the ﬁ rst signs of spreading out could be detected 
under the light microscope. Therefore, for all subsequent experiments, 60 minutes was 
taken as a cut-off point. 
The bar graphs in ﬁ gure 2 show the results of adhesion after preincubation of the meso-
thelial cells with the different serum samples of the 9 individual patients. Compared with 
the percentage adhesion observed with serum obtained one day prior to surgery (-24 
hr), no statistically signiﬁ cant changes in the percentage adhesion were observed after 
incubation with serum at the start of the surgical procedure (0 hr) and 2, 4, 8, 12, 24 
and 48 hr during and after surgery. As shown in ﬁ gure 2 the adhesion of Caco-2 cells to 
the mesothelial cells from the different patients varies between 20-55%. The variability of 
the adhesion of Caco-2 cells to the different donors was also observed within incubation 
with pooled human serum, suggesting intrinsic differences between the mesothelial cells 
obtained from different patients in their capacity to cause Caco-2 adhesion. Figure 3 
shows the mean adhesion of the 9 patients, including the control with human pooled 
serum. No signiﬁ cant difference in adhesion was observed between the control group 
and the serum samples taken from the patients. 
DISCUSSION
Tumour metastasis following curative surgery has been a relentless hurdle for patients with 
colorectal cancer. Tumour recurrence after surgery has been studied in various animal 
models. These studies concluded that tumour recurrence is enhanced by surgical trauma 
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Figure 3
Mean adhesion of Caco-2 cells to monolayer mesothelium pre-incubated with serum samples of the 9 
patient at 8 different periods. Data are expressed as the mean (n=8) +SEM. The ﬁ rst bar shows the 
control adhesion of Caco-2 cells on mesothelial cells incubated in human pooled serum overnight. 
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and that the expanse of tumour growth is dependent on the severity of surgical trauma.14-
19 Despite all these animal models, the mechanism of tumour recurrence is still unclear. 
Which factors are involved and whether it is a systemic or local stimulated process is still 
open to question. 
Local tumour recurrence is a multistep process in which several factors are involved. 
Serum is a the total complex of cytokines, soluble adhesion molecules and growth fac-
tors. In this model we have chosen to use whole serum, because it is not known if tumour 
recurrence is inﬂ uenced by systemic factors. It is important to investigate ﬁ rst if the serum 
is inﬂ uencing tumour adhesion, before you extract different factors from the serum and 
study them individually.
In this study we have evaluated whether systemic inﬂ uences on local tumour recurrence 
can be involved. In our cell adhesion model post-operative serum did not enhance adhe-
sion of Caco-2 cells to incubated mesothelium. This suggests that systemic factors are not 
a main cause inﬂ uencing the adhesion of spilled tumour cells. 
However, several other explanations for the absence of an inﬂ uence of post-surgical 
serum on tumour cell adhesion need to be discussed as well.
1) The concentration of factors that could potentially inﬂ uence tumour cell adhesion may 
be too low. In previous studies we showed that 1 ng/ml IL-1β or TNF-α can enhance 
tumour cell adhesion to the mesothelium.20 The concentration of IL-6 in serum in normal 
healthy patients is < 100 pg/ml and levels of IL-1β and TNF-α are not detectable in 
serum. 21
2) The absence of enhancement of tumour adhesion may be explained by blockade of 
ICAM-1 and VCAM-1 receptors by soluble ICAM-1 and VCAM-1. In vivo, the function of 
soluble ICAM-1 and VCAM-1 is that they have been shed of the tumour cells, in order to 
block the counterligands on immunocompetent recognition lymphocytes and in that way 
promote metastasis development.8,9
In addition, another interesting observation is that inﬂ ammatory cytokines such as IL-1β 
or TNF-α are detectable in higher concentrations (>1000 pg/ml) in the drainage ﬂ uid 
of the thorax and abdominal cavity.21 Taken this consideration, local tumour recurrence 
may be more potently inﬂ uenced by locally produced factors.
The basal adhesion of colon carcinoma cells to the mesothelium, after incubation with 
serum a day before surgery and control human pooled serum, varies between 20-60%. 
Variations in basal adhesion are caused by inter-individual differences of mesothelial 
cells, which is the only variable in this model, but of the utmost importance in vivo. These 
differences of the mesothelium may lead to the inter-individual variations in tumour recur-
rence after curative colon surgery. 
In conclusion tumour recurrence might be inﬂ uenced by substances of the cocktail of 
intra-abdominal produced mediators, which have conﬂ icting demeanor regarding 
wound healing and local tumour recurrence. In addition to the inﬂ uence of these locally 
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produced factors, this study shows that systemic factors produced directly after surgery 
are not a main factor inﬂ uencing tumour cell adhesion. More research is required to 
investigate if systemic factors can stimulate distant metastasis and in which manner local 
tumour recurrence is inﬂ uenced. Such knowledge may lead to novel therapeutic options 
using compounds interfering with this process. 
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ABSTRACT
The presence of foreign material in the abdominal cavity during surgery irritates the 
peritoneal surface leading to an inﬂ ammatory reaction of the peritoneum. This defensive 
mechanism can provoke adhesion formation. The same peritoneal defence cascade is 
thought to play a role in the process of intra-abdominal tumour recurrence. The aim of 
this study was to compare 4 different types of gloves and their inﬂ uence on tumour cell 
adhesion to human mesothelial cells in a in vitro model.
An experimental human in vitro model was designed using Caco2 colon carcinoma 
cells. For all studies, primary cultures of omentum derived mesothelial cells were used. 
Tumour cell adhesion to a mesothelial monolayer was assessed after pre-incubation of 
the mesothelium with powdered and non- powdered gloves solutions. In this model we 
have used Baxter (powdered), Romed (powdered), Biogel (non-powdered) and non-latex 
Biogel(non-powdered) gloves. 
These results showed that only the non-latex powder free glove solution does not increase 
the tumour cell adhesion to a mesothelial monolayer. From previous in vivo rat studies 
we know that powder leads to increased adhesion and growth of free intra-abdominal 
tumour cells. This study shows that beside powder the pure latex particles can enhance 
the tumour recurrence as well. The presence of latex proteins may aggravate the normal 
inﬂ ammatory reaction to tissue injury and therefore enhance tumour adhesion to the 
peritoneum.
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INTRODUCTION
The presence of foreign material in the abdominal cavity during surgery may irritate the 
peritoneal surface leading to an inﬂ ammatory reaction of the peritoneum. This defensive 
mechanism can provoke adhesion formation. The same peritoneal defence cascade is 
thought to play a role in the process of intra-abdominal tumour recurrence. 
Following potentially curative resection of gastro-intestinal carcinoma, local recurrence 
and peritoneal dissemination are common in tumour recurrence.1 Distribution patterns of 
ﬁ rst peritoneal recurrence show that the resection site is preferential, and combined recur-
rence on peritoneal surfaces and resection site is common.2 Early preoperative tumour 
cell seeding and preoperative shedding of tumour cells, due to handling the tumour and 
leakage from dissected lymphatic channels, are the most likely causes of tumour recur-
rence. The tumour cell entrapment theory proposes that the ﬁ brinous exudates, formed as 
an initial response to surgical trauma of the peritoneum, facilitates implantation of cancer 
cells onto raw tissue.2 The dynamic cascade of peritoneal healing, induced by peritoneal 
damage, leading to adhesion formation also seems to be important in the process of 
intra-peritoneal adhesion and growth of tumour cells. Indeed, previously described clini-
cal and experimental studies showed that surgical trauma may promote intra-abdominal 
recurrence.3-5 The degree of inﬂ icted trauma correlated with the extent of intra-abdominal 
tumour load.5 In previous studies we investigated the contribution of glove powder on 
local tumour take in vivo.6 It appears that glove powder as well as pure starch leads to 
enhanced tumour take. Since good powder free alternatives are available, most hospitals 
are not using powdered gloves anymore during intra-abdominal surgery. The aim of this 
study was to compare four different types of powdered and non-powdered gloves and 
their inﬂ uence on tumour cell adhesion to human mesothelial cells in a in vitro model.
MATERIALS AND METHODS
Culture of omental mesothelial cells
Mesothelial cells (MC) were obtained from the omental tissue of patients undergoing elective abdominal 
surgery who had given informed consent. The MC were isolated according to techniques modiﬁ ed 
from Wu et al.7 The omentum was transferred to ﬂ uid containing 0.05% trypsin-0.02% EDTA (Invitrogen, 
Karlsruhe, Germany). After 15 minutes the detached MC were pelleted by centrifugation at 1800 rpm for 
10 minutes and were resuspended in RPMI 1640 supplemented with 10% foetal calf serum, L-glutamin 
(200 mmol/L) and penicillin (5000 U/ml)(Invitrogen, Karlsruhe, Germany). MC were grown until 
conﬂ uence in a 37ºC, fully humidiﬁ ed, 5% CO2 cabinet in polystyrene culture ﬂ asks (75 cm
2, Corning BV, 
Schiphol-Rijk, The Netherlands) pre-coated with collagen type I (17.5 μg/ cm2 ). 
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Tumour cell line
The human colon adenocarcinoma Caco-2 was a kind gift of Dr. W. Dinjens. The cell line was cultured 
in RPMI1640 medium supplemented with 10% foetal calf serum, L-glutamin (200 mmol/L) and penicillin 
(5000 U/ml). All supplements were obtained from Invitrogen, Karlsruhe, Germany. Before use, cells were 
trypsinized (5 minutes at 37ºC), centrifuged (5 minutes at 1500 rpm), resuspended in RPMI 1640 and 
counted. Viability was measured by trypan blue exclusion and always exceeded 95 percent.
Surgical gloves; isolation of latex
The gloves we have used were manufactured by three different companies. In this study we have used 
Baxter (powdered), Romed (powdered), Biogel (non-powdered) and non-latex Biogel(non-powdered) 
gloves. The gloves were cut in pieces of 1x1 cm. The latex allergens were prepared by extracting the 
pieces in phosphate buffered saline (PBS), pH 7.4, containing 0.03% human serum albumin and 0.5% 
phenol during 72 hours at 4°C. The supernatants were collected and dialysed with a 3500 d molecular 
weight cutoff membrane (Molecularpouros Dialyses Membrane, Spectrum, Canada) against deionised 
water for 72 hours. The dialyzate was centrifuged at 13,000 g for 15 minutes, and the supernatant were 
ﬁ lter sterilised with a 0.22 μm Millex GS ﬁ lter (Millipore, The Netherlands) and freeze-dried. A 1% dilution 
in PBS was made from the freeze-dried material.8
Calcein-AM solution and incubation
The dye solution, calcein-AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 μg calcein (Molecular Probes, Leiden, The Netherlands) in 5 μl anhydrous dimethyl sulphoxide 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) and adding this solution to 5 ml of RPMI 1640 medium 
supplemented with 0.5% bovine serum albumin (RPMI 1640/0.5%BSA, BSA obtained from Sigma-
Aldrich). Trypsinized Caco2 and HT29 cells (1x106 cells/ml) were incubated in RPMI1640/0.5%BSA at 
37 ºC for 30 minutes with occasional mixing.
Adhesion assay
To quantify tumour cell adhesion to a monolayer mesothelium, a standardised cell adhesion assay was 
developed according to methods from Catterall et al.9 Mesothelial monolayers were established in 96 
well plates (Canberra Packerd, Groningen, The Netherlands), pre-coated with collagen type I (15 μg/
cm2, coating according to instructions of the manufacturer). To do this, conﬂ uent cells were washed with 
phosphate buffered saline (PBS) and harvested with trypsin (0.05%) and EDTA (0.02%) and 2.5 x 104 
mesothelial cells were added in 200 μl of medium to each well. The plates were incubated at 37 ºC, in 
a humidiﬁ ed atmosphere of 5% CO2 in air; medium was replaced daily with fresh medium. Monolayers 
reached conﬂ uence in 5 to 7 days as determined by light microscopy. In order to determine the effect of 
the latex on tumour cell adhesion, mesothelial monolayers were pre-incubated with increasing doses. Non 
pre-incubated mesothelial monolayers served as controls.
Tumour cells were labelled with calcein as described above. Before adding to the mesothelial monolayers, 
the labelled cells were washed twice with RPMI1640/0.5%BSA to remove free dye.
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Medium from the experimental wells was removed and 200 μl RPMI1640/0.5%BSA containing 30,000 
calcein labelled tumour cells was added. Plates were centrifuged for 1 minute at 80 g on a Perkin Elmer 
centrifuge and incubated at 37 ºC for 60 minutes. After this, the medium of each well was removed and 
washed twice with 200 μl RPMI1640/0.5% BSA medium. The remaining ﬂ uorescence per well was 
measured on a Perkin Elmer plate reader using 485 excitation and 530 emission ﬁ lters. On each plate a 
standard was prepared by adding different numbers of labelled tumour cells to the wells. The amount of 
tumour cells adhered was determined by calibrating the measured ﬂ uorescence of the experimental wells 
on the standard.
DNA-assay
To investigate whether overnight incubation of the mesothelial monolayer with the different latex solutions 
was inﬂ uencing the cell growth, a DNA measurement was performed. In this assay, the DNA content 
of the mesothelial cells was measured using the bisbenzimide ﬂ uorescent dye (Roch Diagnostics) as 
previously described by Hoﬂ and et al.10 In short, at the end of the incubation period the plates were 
washed twice with saline and stored at -20°C until further analysis. The cells were extracted with 
ammonia solution (1 mmol/L) – Triton x 100 (0.2% v/v) by soniﬁ cation during 5 seconds at amplitude 
15 (Soniprep 150; MSE). Thereafter assay buffer (100 mmol/L NaCl, 10 mmol/L EDTA, 10 mmol/L 
Tris; pH 7.0) was added. The remaining solution was centrifuged at 2000 g during 5 min and 100 μl 
aliquots of the supernatant was mixed with 2 ml Hoechst dye H33258 (100 μg/L). Fluorescence was 
measured after 10 min with the excitation and emission wavelengths set at 350 and 455 nm respectively. 
The ﬂ uorescence of experimental samples were referenced to a standard curve of calf thymus DNA (type 
II, no D-3636; Sigma, Zwijndrecht, The Netherlands).
Statistical analysis
All data were analysed using analysis of variance (ANOVA) to determine overall differences between 
group means. If the ANOVA was signiﬁ cant on a 5% level, the post-hoc Newman-Keuls test was carried 
out to make a comparison between groups. P≤ 0.05 was considered to be statistically signiﬁ cant. 
Experiments were carried out at least twice with comparable results.
RESULTS
Morphology and growth of mesothelial cells
Mesothelial cells were isolated from omental tissue and brought into culture. The ﬁ rst 
days of culture the mesothelial cells spread out to make contact to each other and form 
a monolayer. After 5 to 7 days there is a monolayer and also the typical cobblestone 
appearance (ﬁ gure 1, chapter 6).
Before we started the adhesion experiments the vitality of the mesothelial cells was 
measured after incubation with different concentrations of the latex solutions by means 
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of trypan blue coloring. The ideal concentration for all the different latex solutions was 
0.125%. Incubating the mesothelial cells with this concentration did not inﬂ uence the 
morphology of the cells microscopically. This concentration of latex was not inﬂ uencing 
the growth of the mesothelial monolayers as well (data not shown).
Adhesion assay
In the control situation the average adhesion of Caco2 cells to the mesothelial mono-
layers was 20%. Pre-incubation of the monolayer mesothelium with a 0.125% Romed 
solution resulted in an average of 40% enhanced tumour cell adhesion compared to the 
control situation (p<0.001). Pre-incubation with 0.125% Baxter solution increased the 
tumour cell adhesion with 30% (p<0.01). Biogel solution resulted in a 20% enhancement 
of tumour cell adhesion (p>0.05). The non-latex Biogel solution did not affect the amount 
of tumour cell adhesion (ﬁ gure 1). 
Table 1 shows the signiﬁ cance levels between all groups. There was a signiﬁ cant difference 
in tumour cell adhesion between the Romed gloves and the non-powdered Biogel gloves.
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Figure 1
The effect of the number of wash steps after 1 hour incubation of HT29 and Caco2 on collagen I. 
Means (n=6) ± SEM are shown.
Table 1 
Control Romed Baxter Biogel Non-latex
Control <0.001 <0.01 ns ns
Romed <0.001 ns <0.05 <0.001
Baxter <0.01 ns ns <0.01
Biogel ns <0.05 ns ns
Non-latex ns <0.001 <0.01 ns
Levels of signiﬁ cance between all groups. P≤ 0.05 was considered to be statistically 
signiﬁ cant. 
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DISCUSSION
Since the introduction of gloves by William S. Halsted in 1896, several materials and 
lubricants have been used in the glove industry to facilitate manufacturing and to lessen 
the hazards associated with glove use.11 Modern gloves are made of natural rubber 
(latex) or synthetic rubber (vinyl or polyvinyl). The glove lubricants are powder (starch) or 
hydrogel. Glove lubricants have been associated with a number of iatrogenic problems 
in surgical patients. Especially starch powder in surgical gloves can lead to serious 
complications such as granulomatous peritonitis, adhesion formation and infection po-
tentiation.12 Previous experiments done in our laboratory showed that powder increases 
adhesion formation as well as tumour cell adhesion and growth in an in vivo rat model.6 
In the current in vitro experiments the latex solutions increase the tumour adhesion as well. 
The non-powdered Biogel and the non-latex Biogel solution did not increase adhesion of 
tumour cells. The enhancement of tumour adhesion by the presence of latex proteins may 
be caused by an aggravation of the normal inﬂ ammatory reaction to tissue injury which 
enhances tumour adhesion to the peritoneum. In peritoneal wound healing inﬂ ammatory 
and mesothelial cells produce an abundance of cytokines and growth factors which 
might be beneﬁ cial for tumour cell adhesion and tumour growth.13-15 What we know from 
other studies is that there is a signiﬁ cant correlation between the intensity of trauma to the 
peritoneum and the degree of tumour recurrence.16 The most impressive enhancement of 
tumour was seen after incubation with the Romed (40%) and Baxter (30%) latex solutions. 
These are powdered gloves. This enhancement is probably caused by an increased re-
lease of cytokines by the mesothelial cells after pre-incubation induced by starch powder 
in combination with the latex particles in these solutions. Despite evidence in support 
of starch induced complications, a considerable number of surgeons continues to wear 
starch powdered gloves.17 The non-powdered Biogel glove solution did not increase the 
tumour cell adhesion signiﬁ cantly. The non-latex gloves are not inﬂ uencing the tumour 
cell adhesion at all. A logical conclusion might be that we should operate with non-latex 
gloves. However the disadvantage of non-latex gloves is inferior ﬂ exibility and tactility. 
Therefore the second best option is to use non-powdered gloves during operation. More-
over, the surgeon should abandon all substances which will cause enhanced trauma to 
the peritoneum from the operating theatre and should try to handle the operating ﬁ eld 
very carefully in order to limit surgical trauma of the peritoneum as much as possible. 
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ABSTRACT
In addition to the studies in which the adhesion to mesothelial monolayers was investi-
gated, this chapter describes the results of the studies on the interactions between colon 
cancer cells and the extracellular matrix (ECM). These interactions play a major role in 
intravasation and subsequent extravasation during distant metastasis in colon cancer, 
but are also important in the process of intra-abdominal recurrences in areas of the 
peritoneum where mesothelial cells have been exfoliated.
In an in vitro model the adhesion of the HT29 and Caco2 colon carcinoma cell lines to 
the main components of the ECM, collagen type I and IV, ﬁ bronectin and laminin, was 
investigated. This adhesion was compared to the adhesion to the overlying endothelium 
and mesothelium. Inhibition assays with the use of monoclonal antibodies were per-
formed to study the role of adhesion molecules in tumour cell - ECM interactions. 
We showed that different colon cancer cell lines strongly adhere to the ECM, although 
they express different adhesion patterns to these components. Lower adhesion was seen 
to the endothelium and mesothelium. Knowledge of the integrins involved in tumour cell 
- ECM interactions may lead to new therapeutic strategies to prevent metastasis.
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INTRODUCTION
Despite the development of modern treatment strategies for colon cancer, recurrences 
after intentionally curative surgery remain a major problem. Recurrence rates up to 40% 
have been reported and preferential sites are locally, as well as liver and lungs.1-4 The 
majority of death of colorectal cancer patients is caused by metastatic disease rather 
than the primary tumour.5
Key events in the metastasic cascade comprise of invasion in tumour stroma, intravasa-
tion of the circulatory system at the primary site, survival from defence mechanisms, 
extravasation at the secondary site and outgrowth of new tumours.
At the secondary site, binding to mesothelial or endothelial cells results in retraction with 
discontinuity of the cell layer, thereby exposing the underlying extracellular matrix (ECM).6 
Binding to components of the ECM stimulates the production of matrix metalloproteinases 
which degrade the ECM.7 In this way, the tumour cells can enter the underlying tissue, 
proliferate and grow out to form a metastasis. Tumour cells show a higher binding afﬁ nity 
to the ECM compared to the overlying endothelium or mesothelium.8,9 This difference in 
binding afﬁ nity causes a gradient for the tumour cells into the underlying tissue. In the 
case of trauma to the mesothelial or endothelial cell layer, it is likely that more circulating 
tumour cells are able to adhere and successfully form a metastasis. Trauma may consist 
of direct trauma like the disruption of the mesothelium in case of abdominal surgery or 
indirect trauma like inﬂ ammation.
Major components of the ECM are collagen type I (C I) and IV (C IV), ﬁ bronectin (FN) 
and laminin (LN). Therefore, these components are thought to play an important role in 
cancer metastasis. 
Binding to these components is accomplished by adhesion molecules on tumour cells. 
Both the cellular adhesion molecules ICAM and VCAM and the integrins may play a 
role in this interaction. The very late activation (VLA) antigens form a major subclass of 
integrins which are transmembrane heterodimers consisting of an α and β1 chain. It is 
known that VLA-1 (α1β1), VLA-2 (α2β1) and VLA-3 (α3β1) are able to bind to C I and IV. 
FN act as a ligand for VLA-3 till VLA-5 and LN for VLA-1, -2, -3, -6 and -7.10,11
To study the adhesion of colon cancer cells to components of the ECM and to compare 
this adhesion with adhesion to the covering layer consisting of endothelium or mesothe-
lium we developed a human in vitro model. We used two different human colon cancer 
cell lines, namely the poorly differentiated HT29 cell line and the moderately differenti-
ated Caco2 cell line. The role of the VLA-antigens as well as ICAM-1 and VCAM-1 in 
binding to particular components was evaluated.
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MATERIALS & METHODS
Cells
The human colon carcinoma cell lines HT29 and Caco2 were grown in RPMI 1640 medium 
supplemented with 10% foetal calf serum, glutamine (2 mM) and penicillin (105 U/L) and maintained by 
serial passage after trypsinization using 0.05% trypsin / 0.02% EDTA (all, except penicillin, obtained 
from Invitrogen, Breda, the Netherlands; penicillin from Yamanouchi, Leiderdorp, The Netherlands).
Before the adhesion assay, tumour cells were trypsinized and maintained in suspension culture for 2 hours 
to regenerate cell-surface proteins. 
Human microvascular endothelial cells of the lung (EC) were purchased from Cambrex (Verviers, Belgium) 
at passage 4 and maintained in EGM-2-MV Bullet kit according to the manufacturer at 37°C, 95% 
relative humidity and 5 % CO2. Conﬂ uent monolayers were passaged by 0.025% trypsin / 0.01% EDTA 
and cells were used up to passage 8. 
Human mesothelial cells (MC) are obtained from omental tissue of patients undergoing elective abdominal 
surgery. Isolation of the cells was accomplished using modiﬁ ed techniques from Wu et al.12 To detach 
MC from the omentum, 0.05% Trypsin with 0.02% EDTA is used. Next, MC are resuspended in RPMI-
1640 medium supplemented with 10% FCS, 2 mM glutamine (all Invitrogen) and penicillin (105 U/L) 
and brought into culture in collagen coated culture ﬂ asks at 37°C, 95% relative humidity and 5 % CO2. 
Conﬂ uent monolayers were passaged by 0.05% trypsin / 0.02% EDTA.
Adhesion assay
To quantify tumour cell adhesion to components of the ECM, to EC and to MC monolayers, a 
standardised cell adhesion assay was developed according to methods from Catterall et al.13 Flat-
bottomed 96 well microtiter plates (Perkin Elmer, Groningen, The Netherlands) were coated with 20 μg/
ml C I, C IV (Sigma-Aldrich, Zwijndrecht, the Netherlands), FN or LN (Boehringen-Mannheim, Mannheim, 
Germany). To block unspeciﬁ c binding sites, wells were pre-incubated with 1% BSA for 30 minutes. 
To obtain endothelial and mesothelial monolayers, conﬂ uent cells were trypsinized and 2×104 EC and 
1×104 MC were added to each well. The plates were incubated at 37°C, 95% relative humidity, 
5% CO2 and medium was daily replaced by fresh medium. EC reached conﬂ uence in 3 to 4 days as 
determined by light microscopy. For MC, conﬂ uence was achieved after 5 days.
To quantify tumour cell adhesion, trypsinized tumour cells (1×106 cells/ml) were labelled with calcein-AM 
(Molecular Probes, Leiden, The Netherlands) and 3×104 cells per well were added. 
Evaluation of the contribution of integrins in the adhesion of tumour cells to components of the ECM was 
done by pre-incubation of the tumour cells with the function-blocking antibodies anti-α1 till anti-α6, anti-β1 
(BD Biosciences, Alphen a/d Rijn, the Netherlands), anti-ICAM and anti-VCAM (Dako Cytomation, 
Heverlee, Belgium) in a concentration of 1 μg/ml for 30 minutes at room temperature before adding the 
tumour cells to the wells. 
Plates were centrifuged for 1 minute at 80 × g in a Heraeus centrifuge and incubated at 37°C for 1 hour. 
After this, wells were washed twice with medium to remove non-adherent tumour cells. The remaining 
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ﬂ uorescence per well was measured on a Perkin Elmer plate reader using 485 nm excitation and 530 nm 
emission ﬁ lters. 
Immunocytochemistry of adhesion molecules
Tumour cells were prepared for staining by cytospin preparation, ﬁ xed in acetone for 10 minutes and 
stored at -20°C until use. 
The cytospins were incubated for 30 minutes at room temperature with the following primary antibodies: 
mouse anti-human monoclonal antibodies to α1 till α6, β1 (BD Biosciences, Alphen a/d Rijn, the 
Netherlands), ICAM-1 and VCAM-1 (Dako Cytomation, Heverlee, Belgium). Negative controls were 
incubated with PBS. As secondary antibodies, biotinylated goat anti-mouse antibodies were used 
followed by incubation with Streptavidin-biotinylated alkalin-phosphatase complex. Substrate development 
was done with New Fuchsine 4%. Cytospins were counterstained with Haematoxiline.
The expression of cell adhesion molecules was quantiﬁ ed by 2 separate observers using semi-quantitative 
scoring system ranging from no expression (-), weakly positive (±) to positive expression (+).
Statistical analysis
All data were analysed using analysis of variance (ANOVA) to determine overall differences between groups. 
The post-hoc Newman-Keuls test was carried out to compare between groups. P ≤ 0.05 was considered to 
be statistically signiﬁ cant. Experiments (n=6) were performed at least twice with comparable results.
RESULTS
Validation of assay
Labelling tumour cells with calcein-AM did not decrease their viability (>95% using trypan 
blue). Incubation times not exceeding 60 minutes gave negligible leakage of calcein out 
of the cells into the medium (data not shown). Longer incubation times gave signiﬁ cant 
calcein loss resulting in unreliable results. Therefore, we used 60 minutes incubation time 
in our experiments. After incubation, three times washing resulted in thorough washing 
away non-adhering tumour cells and leaked calcein from the experimental wells (Fig 1).
Dilution series showed a linear correlation between tumour cell number and measured 
ﬂ uorescence that was used as a standard to calibrate measured ﬂ uorescence. In this way 
the amount of adhered tumour cells in the experimental wells could be determined.
Tumour cell adhesion 
Table 1 shows the adhesion of HT29 and Caco2 to the different components of the ECM 
as well as to endothelial and to mesothelial monolayers. For HT29, highest adhesion 
after 1 hour incubation was achieved to C I, namely 60.9%, followed by adhesion to C 
IV with 46.4%, than LN with 39.6% and lowest adhesion was to FN with 20.6%. Caco2 
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cells showed a different adhesion pattern with highest adhesion to C IV (51.4%), fol-
lowed by adhesion to FN with 48.8%, than to C I with 41.8% and lowest adhesion was 
to LN with 21.9%. To C IV and FN, Caco2 demonstrated a signiﬁ cant higher adhesion 
compared to HT29 (resp. p<0.05 and p<0.01). HT29 showed a signiﬁ cantly higher 
adhesion to C I and LN compared to Caco2 (p<0.01). The adhesion to EC was for 
both tumour cell lines considerably lower compared to the adhesion to the ECM, namely 
12.1% of the HT29 and 21.9% of the Caco2 adhered to EC (p<0.01). Unlike the endo-
thelial cells, which are acquired from a single donor, are the mesothelial cells obtained 
from different donors. Therefore, series of adhesion experiments were performed using 
monolayers of 5 different patients. Highest adhesion was found for Caco2 with 34.1% 
of the cells adhering. The mean adhesion of HT29 to MC was 21.4% of the cells. 
Both cell lines showed low afﬁ nity for uncoated wells, with only 2.4% of HT29 cells and 
5.7% of Caco2 cells adhering to the plastic of the experimental wells.
Adhesion to collagen I
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Figure 1
The effect of the number of wash steps after 1 hour incubation of HT29 and Caco2 on collagen I. 
Means (n=6) ± SEM are shown.
Table 1. 
Substrate C I C IV FN LN EC MC plastic
HT29 60.9 ± 2.1 46.4 ± 1.4 20.9 ± 2.7 39.6 ± 6.8 12.1 ± 2.0 21.4 ± 5 2.4 ± 0.8
Caco2 41.8 ± 4.0 51.4 ± 3.3 48.8 ± 5.7 21.9 ± 1.6 21.9 ± 3.4 34.1 ± 5 5.7 ± 0.5
Adhesion of HT29 and Caco2 to various substrates: components of the extracellular matrix, 
endothelial cells, mesothelial cells and to empty experimental wells (plastic). Data are expressed as 
the mean (n=6, % vs total) ± SD.
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Expression of integrins, ICAM and VCAM
Table 2 shows the immunocytochemistry results of the tumour cells. Except for the α4-
component, all α-components are expressed on HT29. The α1- and α5-components are 
only weakly expressed. On Caco2, all α-components are expressed, although the α1-, 
α4- and α5-components show only weak expression. The β-component is expressed on 
both tumour cell lines, as well as ICAM-1 and VCAM-1.
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Figure 2 
Adhesion of HT29 to different components of the ECM. Tumour cells were pre-incubated with 
antibodies against α1-6, β1, ICAM-1 and VCAM-1 (1 μg/ml). Data represent means (n=6, % vs. 
control) ± SEM. *, p < 0.01.
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Inhibition assays
Inhibition assays using functional blocking antibodies to components of integrins are 
shown in ﬁ gure 2 (HT29) and 3 (Caco2). Adding antibodies against the α2 component 
gave a signiﬁ cant reduction of 64.9% (p<0.01) in HT29 cell adhesion to C I and of 
30% (p<0.01) to C IV. For Caco2 a reduction of 46.8% was found by adding the 
α2-antibody in the adhesion to C I and of 39.9% to C IV. Addition of the α4-antibody 
resulted only for Caco2 in a signiﬁ cant reduction in the adhesion to C IV, namely 26.3%. 
Almost complete inhibition in HT29 cell adhesion to LN was achieved by addition of 
the α6-antibody, since this antibody reduces adhesion with 96.1% (p<0.01). For Caco2 
cells, no signiﬁ cant reduction was observed using the α6-antibody in the adhesion to LN. 
Neither antibodies to other α-components, nor antibodies to the β1-component, ICAM-1 
and VCAM-1 gave an inhibition to ECM components.
DISCUSSION
The capacity for adhesion seems a contradiction in tumour metastasis, in which the ﬁ rst 
step the detachment of the tumour cell from the primary site is. However, detachment and 
adhesion are necessary steps and form a delicate balance in metastasis. Interactions 
between colon cancer cells and components of the ECM are thought to play a major 
role in intravasation and subsequent extravasation during the metastatic cascade in colon 
cancer. The purpose of this study was to analyse these interactions.
High adhesion was found for the HT29 and Caco2 colon cancer cell lines to the various 
components of the ECM, although each cell line displays its own adhesion pattern. For 
HT29, 60.9% of the cells attached to C I and 40% or more to C IV and LN. Lowest 
adhesion was seen to FN with only 20.6% of HT29 adhering. More than 50% of the 
Caco2 cells adhered to C IV, 48.8% and 41.8% of the Caco2 cells adhered to FN and 
Table 2. 
antibody HT29 Caco2
 α1 +/- +/-
 α2 + +
 α3 + +
 α4 - +/-
 α5 +/- +/-
 α6 + +
 β1 + +
 ICAM + +
 VCAM + +
Cell adhesion molecules expressed by HT29 and Caco2 as found by immunocytochemistry. 
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C I respectively. Here, lowest adhesion was to LN with only 21.9% of the cells adhering. 
This individual adhesion pattern for various types of colon cancer cell lines was also 
found by Schlaeppi et al,14 who compared 4 different colon carcinoma cell lines in their 
adhesion and invasion to various components of the ECM.
A preceding step in extravasation is adhesion to the mesothelium locoregionally or the 
microvascular endothelium at secondary sites. To the mesothelium the adhesion varied 
between different donors with each having their unique characteristics. Here, again 
a difference was observed between the 2 tumour cell lines, with a signiﬁ cant higher 
adhesion for Caco2 compared to HT29 to the mesothelium and to the microvascular 
endothelium.
In this study we found a high adhesion to individual components of the ECM. In order 
to be able to dissect the individual ECM component, we did not measure the adhesion 
to a complete ECM consisting of a mixture of the tested components and additional 
components like hyaluronic acid. Adhesion to a complete ECM may bring about even 
higher numbers of adherent cells and thereby creates a more pronounced difference in 
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Figure 3
Adhesion of Caco2 to different components of the ECM. Tumour cells were pre-incubated with 
antibodies against α1-6, β1, ICAM-1 and VCAM-1 (1 μg/ml). Data represent means (n=6, % vs. 
control) ± SEM. *, p < 0.01.
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adhesion afﬁ nity between the endothelium and ECM and perhaps also between the 
mesothelium and ECM leading to a stronger invasion gradient. 
In our experiments, HT29 shows slightly lower adhesion to both the endothelium and me-
sothelium and higher adhesion to ECM components compared to Caco2 and therefore 
the invasion gradient seems more pronounced for HT29, a poorly differentiated colon 
carcinoma cell line, than for Caco2 which is a more differentiated cell line. 
Recently, we investigated the inﬂ uence of an inﬂ ammatory reaction on tumour cell – endo-
thelial cell interactions.15 In these studies we found that pre-incubation of the endothelium 
with pro-inﬂ ammatory cytokines or reactive oxygen species, that are produced by acti-
vated leukocytes, brings about an increase in tumour cell adhesion to the endothelium. 
This pre-incubation resulted in a signiﬁ cant increase in apoptosis of endothelial cells. In 
the early phase of apoptosis the cells are activated with increased expression of adhe-
sion molecules resulting in enhancement of tumour cell adhesion. Eventually, cell death 
occurs with exposure of the underlying ECM. Therefore, inﬂ ammation, but also direct 
mechanical disruption of the covering monolayer leading to exposure of the ECM may 
cause enhanced tumour recurrence.
By immunocytochemistry, we showed that α2, α3, α6 and β1 are abundantly expressed 
on both tumour cells. ICAM, VCAM, α1, α3 and α4 have modest expression on one or 
both cell lines. These ﬁ ndings are corresponding with the literature.14,16,17 It is known that 
the expression of integrins is versatile with pathways of inside-out and outside-in signal-
ling as means of activation.18-21 Accordingly, the expression of integrins is important, but 
the functionality is even more important. Consequently, inhibition assays using functional 
blocking antibodies were performed to get insight in integrins responsible for adhesion 
to ECM components. These assays clearly display that the binding of HT29 to LN seems 
almost completely formed by the α6-component, which forms the VLA-6 integrin with β1. 
The binding to LN exhibit a discrepancy between the two tumour cell lines, since the 
binding of Caco2 to LN is not signiﬁ cantly inhibitable by the α6-antibody in contrast to 
the binding of HT29. The α2-component was found to play a major role in the binding 
of both tumour cell lines to C I and to a lesser extent to C IV. These ﬁ ndings are partly in 
accordance with the results of Haier et al.22 They used subclones of HT29, namely the 
poorly liver-metastatic colon carcinoma cell line HT29P and the highly liver-metastatic 
colon carcinoma cell line HT29LMM. In their study the α2-antibody comparably sup-
pressed the adhesion of both cell lines to C I and IV, but the α6-antibody gave only a 
minor reduction in the adhesion to LN. Nonetheless, cell lines may not be comparable, 
since they used HT29 cell lines originating from liver metastases and we from primary 
tumours and therefore it is possible that these cell lines originate from different subgroups 
with different characteristics.
The next step in the metastatic cascade after binding to the ECM is invasion through 
this layer. It is believed that by binding to the ECM matrix metalloproteinases (MMP) 
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are produced or activated which degrade the ECM. As yet, the role of integrins in the 
degradation of the ECM has to be unravelled.
In summary, we showed that different colon cancer cell lines express a high binding 
afﬁ nity to components of the ECM but that their adhesion pattern varies. At present, the 
identity of molecules involved in these interactions remains indeﬁ nitive, because of the 
complexity of which the ECM consist and because of the heterogeneity between tumour 
cells. Knowledge on the selective or more universally expressed integrins involved in 
tumour cell adhesion to the ECM as well as to the EC and MC may be of help for the 
development of a cocktail of antibodies aimed at integrins. This cocktail may prove a 
powerful tool in the prevention of tumour recurrence.
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DISCUSSION
The process of cancer metastasis could be compared with an exhausting obstacle race, 
during which the tumour cell has to pass a series of sequential interrelated steps to 
become a clinically relevant lesion. In distant metastasis the tumour cell must succeed 
in invasion, embolisation, survival in the circulation, adhere to a distant capillary endo-
thelium, followed by extravasation and multiplication in another organ.1, 2 Locoregional 
tumour recurrence after intra abdominal seeding or spill of tumour cells seems to be less 
complicated, the tumour cell has to adhere, after which it can ﬂ ourish and grow out as 
a lesion.
Although the process of locoregional tumour recurrence gives the impression to be highly 
comprehensible, peritoneal and local recurrence is a persistent hurdle after curative re-
section of colon or pancreatic tumours.3-7 The resection site is preferable and recurrence 
to locoregional sites is common.8 Several theories on local tumour recurrence have been 
advocated. The most feasible theory is the development of local recurrence after resec-
tion of locally advanced disease, which already penetrates the peritoneal surface or 
adjacent organs. Another source for local recurrence is the presence of cancer cells in 
the abdominal cavity prior or during surgery. Peritoneal washings, before manipulation 
of the tumour, are positive in 20-30% of the patients with colorectal cancer.9-12 Further-
more, extensive manipulation of the tumour during surgery will cause leakage of tumour 
cells out of the dissected lesion or out of the transected lymphatic channels or veins. The 
free ﬂ oating tumour cells or tumour emboli will precipitate on raw tissue, followed by an 
inﬂ ammatory response during which an outstanding environment for the tumour cells will 
be created.8, 13
Approximately 40% of the patients with colorectal cancer, who underwent surgery for 
local or locally advanced disease, develop recurrent disease.7 The intra-abdominal re-
currence rate after curative resection for pancreatic cancer is even more deplorable. 
Methods of prevention and treatment of locoregional metastasis, like neoadjuvant radio-
therapy, brachytherapy, adjuvant chemotherapy, photodynamic therapy, (hyperthermic) 
intraperitoneal chemotherapy and peritonectomy, are developed and implemented in 
daily surgical practice.14-20 The beneﬁ t of adjuvant chemotherapy on overall survival for 
patients with node-positive, locally advanced colon cancer is well established.21 The 
adjuvant therapy regimen in pancreatic cancer has not been elucidated yet. The ESPAC-
1 randomized controlled trial showed no survival beneﬁ t for adjuvant chemoradiotherapy 
after R0 resection, however it revealed a potential beneﬁ t for adjuvant chemotherapy.22 
However a study from Smeenk et al. showed that adjuvant chemoradiotherapy, after 
irradical resections of pancreatic cancer, gives a signiﬁ cant improvement of local control, 
nevertheless treatment with chemoradiotherapy does not improve survival.23 
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These (neo)adjuvant treatment strategies are mainly based on diminishing advanced 
disease. An adequate understanding of the pathophysiology of the tumour cell adher-
ence is needed to clarify the initial step of implantation. The experiments described in 
this thesis were aimed at exploring and unravelling mechanisms of adherence of tumour 
cells to human mesothelial monolayers.
The experimental model
The process of tumour recurrence can be separated into tumour cell adhesion and tumour 
growth. Initially the tumour cells have to adhere before they nurture and develop into a 
metastatic lesion. To study the speciﬁ c pathways of tumour cell adhesion we developed 
an in vitro model, in which we investigated the interactions of different human colon and 
pancreatic tumour cell lines on mesothelial monolayers, derived from human omental 
tissue. The use of primary cultures of human mesothelial cells may have potential pitfalls. 
For example, the culture of mesothelial cells can be contaminated by an overgrowth of 
ﬁ broblasts. Therefore, it is important to identify the primary cultures of mesothelial cells by 
immunocytological staining with monoclonal antibodies after every isolation from omen-
tal tissue. The identity of mesothelial cells is demonstrated by the absence of von Wil-
lebrand factor and the presence of intracellular vimentin and keratin. Optimal isolations 
of mesothelial cells can be achieved by incubating the omental tissue for 20 minutes in 
0.25% trypsin. Minimal tissue manipulation and early collection of the omental tissue dur-
ing surgery may minimise ﬁ broblast contamination.24, 25 An additional drawback in the 
use of primary cultures is the early senescence of the mesothelial cells. For that reason the 
cells should only be used during the second and third passage. Because the amount of 
mesothelial cells isolated from 10 cm2 omental tissue is limited, we used different cultures 
of mesothelial cells. The difﬁ culty by using cultures from different patients is the variation 
in basal adhesion. These inter-individual differences are a hurdle during in vitro investiga-
tions, nevertheless very important in vivo. This objectivity might explain the inter-individual 
variations in tumour recurrence and responses to different cancer therapies. The experi-
ments described in chapter 6 exhibit the inter-individual differences in basal adhesion of 
tumour cells to the mesothelial monolayers. The basal adhesion varied between 20-55%, 
although no variation in enhancement of adhesion was observed after incubation of the 
different mesothelial monolayers with the serum samples obtained per-operatively.
Inflammatory mediators of tumour cell adhesion
This thesis focuses on the inﬂ uence of surgical derived inﬂ ammatory factors on tumour 
cell adhesion. Our data showed that IL-1β and TNF-α are crucial enhancing factors of 
tumour cell adhesion to the mesothelial monolayers. The results described in chapter 2 
and 3 revealed a signiﬁ cant enhancement of adhesion of Caco-2, HT29, Mia-PaCa-2 
and BxPC-3 to mesothelial monolayers, after incubating the mesothelium with IL-1β or 
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TNF-α. In addition IL-1β and TNF-α signiﬁ cantly upregulated the expression of adhesion 
molecules ICAM-1, VCAM-1 and CD44 on mesothelial cells. 
These cytokines are produced during the acute inﬂ ammatory response, which is induced 
by peritoneal trauma and has to initiate the wound healing process.26, 27 IL-1β, TNF-α 
and IL-6, produced by activated leukocytes, are the major mediators of inﬂ ammation 
and tumourigenesis.28, 29 Together they generate the production of adhesion molecules, 
growth factors, nitric oxide, and the activation of the NF-κB pathway. In that way the 
pro-inﬂ ammatory cytokines will stimulate tumour adhesion, growth and invasion.30, 31 
Furthermore, mesothelial cells have additional active participation in the inﬂ ammatory 
response by producing pro-inﬂ ammatory cytokines and in that way stimulating the expres-
sion of adhesion molecules. TNF-α has a dominant function in the abdominal cavity and 
might modulate the production of ILs from mesothelial cells. Production of IL-1 and IL-8 
by mesothelial cells is enhanced after stimulating the cells with TNF-α. 32, 33 In malignant 
disease, high dose local TNF-α selectively destroys tumour blood vessels and thereby 
induces apoptosis, whereas chronically produced TNF-α may act as an endogenous 
tumour promoter. It contributes to the modulation of the cell, i.c. cell adhesion molecules, 
necessary for tumour spread and growth.30, 34 The inﬂ uence of IL-1β on tumour cell me-
tastasis is inevitable as well. In mouse metastasis models treatment with an IL-1 receptor 
antagonist signiﬁ cantly decreased tumour development. Additionally, IL-1β deﬁ cient mice 
are resistant for developing metastases.35
During the inﬂ ammatory response PMN are attracted to the site of injury, which is medi-
ated by chemotactic factors and pro-inﬂ ammatory cytokines.36, 37 PMN are known to 
aggravate an overwhelming burst of ROS (reactive oxygen species) to destroy invading 
organisms and inducing additional tissue destruction.38, 39 Furthermore this oxidative burst 
can be induced by TNF-α, which causes an upregulating of the FMLP receptors (N-for-
myl-methionyl-leucyl-phenylalanine) on PMN.40, 41 In the studies described in chapter 4 
and 5 FMLP stimulated PMN induce a signiﬁ cant enhancement of tumour cell adhesion. 
Moreover the ROS producing system (X/XO) exhibits an even superior enhancement 
of adhesion of tumour cells to the mesothelium and this enhancement was inhibited by 
anti-oxidant scavengers. 
A pathway of interest is the NF-κB transcription factor pathway in inﬂ ammation and tu-
mour cell adhesion. NF-κB is activated by inﬂ ammatory stimuli and its constitutive activa-
tion is found in cancer.42 NF-κB plays a pivotal role in cellular responses to environmental 
changes, such as stress, inﬂ ammation and infection. NF-κB is activated in response to 
pro-inﬂ ammatory cytokines and ROS, resulting in the production of growth factors, adhe-
sion molecules, immunoreceptors and cytokines are produced.43, 44 
Summarising, the inﬂ ammatory sequelae enhance tumour cell adhesion the mesothelium 
in vitro. The pathways involved are orchestrated in a meticulous way by pro-inﬂ ammatory 
factors produced per-operatively in response to surgical trauma. Interference with these 
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pathways may lead to speciﬁ c tools to conquer the adhesion and growth of spilled 
tumour cells in vivo.
Future directions
Although we did not elucidate the exact mechanism of loco-regional tumour recurrence, 
we believe that we made progress in unravelling several pathways involved in the tumour 
cell adhesion process. However, further investigations are required to fully clarify the 
mechanism of tumour recurrence.
Complementary in vitro investigations are necessary in order to provide insights in the 
recurrence pathway by culturing both mesothelial and tumour cells of the same patient 
and investigate the individual interactions, thereby studying the adherence and release 
of different cytokines, and expression of receptors and adhesion molecules on individual 
tumours. Furthermore, research into the chemokine network on immune cells, mesothelial 
cells and tumour cells can reveal parallels between the pathology of inﬂ ammation and 
cancer recurrence. Preliminary laboratory data show promising results with chemokine-
receptor antagonists.45 However their role in cancer and metastatic disease has not been 
unravelled yet, certainly caused by the enormous number of chemokines and chemokine-
receptors.
Every pathway investigated in vitro must have a descendant in vivo, mimicking as much 
as possible the cascade of biological events leading to the formation of metastasis. The 
disadvantages of rodent models are the major differences in lifespan, body weight, gut 
microﬂ ora and intestinal morphology compared to humans. Another disadvantage is that 
human cancer cell lines only can be investigated in genetically manipulated models. To 
investigate the process of metastases of human cancer cells in an experimental model 
a nude mouse model is inevitable, however this model brings along enormous costs. 
This metastasis model will only succeed if the mice and tumours are speciﬁ c pathogen 
free and maintained under barrier conditions.46 The major advantage of animal models 
nowadays is that models can be genetically manipulated in such a way that hypotheses 
can be addressed more easily.47 However, only proper use and choice of an animal 
model will allow us to investigate and bring us closer to the biologic behaviour of 
metastases. 
’A good model is the model that works for you!’ The in vivo experiments in our labora-
tory were all done in a rat model with the rat CC531 colon carcinoma cell line. Our in 
vivo rat model provided us outstanding results, in particular the outcomes of the tumour 
adhesion and promoting studies and the investigations on the use of scavengers.48-50 
Nonetheless this good reproducible model has its limitations in investigating, because no 
cancer cell lines of human origin can be used.
Using nude mice to study the invasion of human tumour cell lines is unavoidable. How-
ever, the usefulness of the athymic nude mouse as an in vivo model for studying the 
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biology of neoplasms has been limited by the fact that malignant tumours only rarely 
metastasize when ectopicly transplanted.46 However implantation of human tumour cells 
into anatomically relevant organs (orthotopic implantation) results in superior growth and 
metastasis.51, 52 Studies after the introduction of the green ﬂ uorescent protein (GFP) as a 
marker for tumour cells has changed the use of nude models radically. Studies with GFP 
offer great promise in detection single cell metastases in vivo.53
To enhance the knowledge of the tumour recurrence pathways, it might be essential 
to have an in vivo model investigating the cascade of pathways, studied previously in 
vitro.
Clinical applications
Notwithstanding that surgery remains the treatment of choice in colorectal and pancre-
atic cancer, local recurrence after curative surgical resection is an incessant drawback. 
This thesis unravelled different pathways of local tumour recurrence in in vitro studies with 
human cells, nonetheless in what way can our investigational results be implemented in 
clinical practice? 
Per-operative diminishing surgical trauma, by using less traumatic tools, gauzes and 
techniques, seems to be an adequate option. The study done by Bouvy et al. showed 
in a rat model, that laparoscopic surgery is associated with less tumour growth stimula-
tion compared to conventional surgery, due to reduced surgical trauma.54 Additionally 
laparoscopic surgery is correlated with less immunological alterations and this may imply 
less local tumour recurrence as well.55, 56 Lacy et al. showed that laparoscopic-assisted 
colectomy is associated with a signiﬁ cantly lower probability of tumour recurrence and 
a higher probability of overall and cancer-related survival in stage III cancer.57 Although 
the recent publication of Law et al. is not a randomized controlled trial, this study put 
forward a signiﬁ cant survival beneﬁ t for patients, who underwent a laparoscopic resec-
tion in stage I to III colon cancer.58 The two randomized controlled trials, in which 
laparoscopic-assisted colectomy was compared to open surgery, could not reveal this 
beneﬁ t concerning tumour recurrence in the laparoscopic group.57, 59 
Since the expression pattern of adhesion molecules on tumour cells is tremendously div-
ers, it is not feasible to use single monoclonal antibodies to confront spilled tumour cells. 
The development of cell adhesion peptides (i.e. RGD peptide) provide promising results 
by blocking the adherence of tumour cells to the components of the extracellular matrix. 
The use of RGD peptides has been expanded with preliminary results by using the RGD 
peptides for delivering drugs to tumour cells that express certain integrin types after which 
an internalization process takes place of the integrin adhesion complex.60, 61
Interfering with the inﬂ ammatory process during and after surgery is a reliable option to 
prevent tumour recurrence, however wound healing is depending on this process. This 
interference should be very selective, otherwise the healing process will be disturbed. 
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Interference with the inﬂ ammatory response might be accomplished by inhibiting the 
inﬂ ux of PMN into the peritoneal cavity with anti-neutrophil serum (ANS) after curative 
resections of gastro-intestinal tumours. An in vivo study showed a signiﬁ cantly decrease 
of peritoneal tumour recurrence after intra-peritoneal injection of ANS.62
Another pathway of interest is the inﬂ uence of ROS on tumour cell adhesion. Accumula-
tion inhibitors of ROS are superoxide dismutase, catalases, gluthatione peroxidases, 
vitamins C and E, these antioxidant enzymes and non-enzymatic systems are engineered 
during stress. Since the release of ROS is enormous following surgical trauma, additional 
exogenous administration of antioxidants might be a therapeutical option. 
An antioxidant with potential is melatonin.63 Melatonin, produced mainly in the pineal 
gland, possesses a wide spectrum of biologic activities, including its function as a natu-
rally occurring oncostatic neurohormone by inhibiting cell proliferation, inducing apopto-
sis and reducin metastatic spread.64-66 Regarding the scavenger function of melatonin, a 
synthetic form might be of interest in prevention of tumour recurrence.
Since the discovery of NF-κB in the mid 1980s, this transcription factor has been a 
subject of intense investigation.67 The NF-κB transcription factor complex is a pleio-
tropic activator that participates in the induction of a wide variety of cellular and viral 
genes. Binding sites for NF-κB are present in the promoter region of many cell adhesion 
molecules, cytokines and growth factors. Antisense inhibition of NF-κB activity causes 
a block of cellular adhesion to the extracellular matrix, inhibition of in vivo growth of 
adherent cells, and inhibition of in vivo tumourigenicity in nude mouse models.68-70 Recent 
investigations also showed that ROS is engaged in a unique reciprocal cross talk with 
NF-κB.71 The exact mechanism has not been unravelled yet, however remarkable is that 
the induction of NF-κB is abrogated by overexpression of ROS scavenging enzymes.72 
A promising NF-κB inhibitor is pentoxifylline (trental), the inhibition of the transcription of 
NF-κB might cause a suppression of cell adhesion molecules and in that way a potential 
decrease of lung metastasis.73 In addition pentoxyﬁ lline may reduce the TNF-α induced 
oxidative burst by reduced binding of FMLP to PMN surface receptors.74
Interference with the invasion of tumour cells through the extracellular matrix is another 
therapeutic option. Matrix metalloproteinases (MMPs), a group of zinc-dependent en-
dopeptidases, play an important role in the growth and invasion of colorectal and 
pancreatic cancers by degradation of the extracellular matrix. The levels of certain MMPs 
can be used to estimate the metastatic capacity and recurrence of disease as well as 
prognosis of patients.75, 76 However, for effective therapy using MMP inhibitors, highly 
selective administration may be required. Since MMP-7 is the most critical MMP for 
colorectal cancer progression, developing selective inhibitors against this protease and 
their administration in the early stage of disease may be worth trying.77
Interference with the inﬂ ammatory sequelae (i.c. cytokines, PMN, ROS, adhesion mol-
ecules, NF-κB) produced per-operatively must be well balanced, without disturbing the 
Helma BW 4.indd   128 03-05-2007   14:26:53
General discussion 129
wound healing process and the systemic immune response. Developing an elixir (con-
taining e.g. ANS, scavengers and/or NF-κB antibodies) to lavage the intra-abdominal 
cavity after surgery, might be the tool to prevent intra-abdominal tumour cell recurrence 
after curative surgical resections. 
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SUMMARY AND CONCLUSIONS
Chapter 1
The general introduction gives an overview of our previous studies, the incidence of 
gastro-intestinal malignancies and the pathophysiology of local tumour recurrence. This 
chapter outlines the basics of the peritoneum, inﬂ ammatory reaction, cytokines, adhesion 
molecules, and the principles of surgery and tumour recurrence. The aim of our study was 
to unravel several pathways of tumour cell adhesion in an in vitro model, in which human 
mesothelial and cancer cells were studied.
Chapter 2
Colorectal cancer accounts for more than 50 percent of the cases of gastro-intestinal 
malignancies. The overall 5 year survival has improved, caused by diverse new adjuvant 
treatment modalities. Nevertheless 40% of the patients develop recurrent disease and the 
5 year survival rate is approximately 35% for patients with local recurrence and 25% for 
patients with distant metastasis. 
In this chapter the in vitro model is described, in which we studied the adhesion of colon 
carcinoma cells, Caco-2 and HT-29, to primary cultures of omental derived human me-
sothelial cells. The adhesion of colon carcinoma cells was investigated after incubation 
of the mesothelial cells with inﬂ ammatory cytokines IL-1β, IL-6 and TNF-α. Tumour cell 
adhesion after incubation with IL-1β and TNF-α was signiﬁ cantly enhanced for both cell 
lines. In comparison with the results of the adhesion experiments, we investigated the 
upregulation of expression of adhesion molecules on the mesothelial cells after cytokine 
incubation. IL-1β and TNF-α signiﬁ cantly enhanced the expression of ICAM-1, VCAM-1 
and CD44 in vitro. These results prove that IL-1β and TNF-α are potential stimulating 
factors of tumour cell adhesion by upregulation the adhesion molecules and in that way 
may account for tumour recurrence in vivo.
Chapter 3
Pancreatic cancer has a tremendously poor prognosis and peritoneal dissemination fre-
quently occurs after surgical resection. The loco-regional recurrence rate ranges between 
38 and 86%. The mechanism of local recurrence has not been unravelled yet. We 
investigated the adhesion of pancreatic cancer cells (Panc-1, Mia-PaCa-2, BxPC-3) to 
mesothelial monolayers, using the in vitro model as described in chapter 3. The adhesion 
of Mia-PaCa-2 and BxPC-3 to mesothelial monolayers is enhanced after incubation the 
mesothelial cells with IL-1β or TNF-α. According to the immunocytochemical staining of 
the pancreatic cancer cells and mesothelial cells and the results of the adhesion assay, 
this study reveals that adhesion molecules ICAM-1 and CD44 are of the utmost impor-
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tance in pancreatic tumour cell adhesion in vitro, and suggests that interference with 
these adhesion molecules may decrease tumour recurrence in vivo.
Chapter 4
Surgery induces an acute phase response, aimed at minimizing damage and starting the 
healing process. During this response speciﬁ c chemoattractants induce the appearance 
of a great number of polymorphonuclear leukocytes (PMN). These PMN are known to 
assemble reactive oxygen species (ROS) to destroy invading organisms. Beside this 
beneﬁ cial effect, the oxidative potential can result in changes of cell function and ad-
ditional tissue destruction. The inﬂ uence of PMN, stimulated PMN and ROS on tumour 
cell adhesion has been studied in this chapter. PMN were stimulated with FMLP and O2
- 
production was determined by measuring the superoxide dismutase inhibitable reduction 
of cytochrome c. The reactive oxygen species (ROS) superoxide and hydrogen peroxide 
were generated by Xanthine Oxidase (XO) upon addition of Xanthine (X). Adhesion of 
colon carcinoma cells, Caco-2, to mesothelial monolayers was signiﬁ cantly enhanced 
after incubation the mesothelial cells with stimulated PMN. Incubation of the mesothelial 
cells with the ROS generating system resulted in a 70% enhancement of tumour cell 
adhesion.
This study showed a signiﬁ cant increased expression of ICAM-1, VCAM-1 and CD44 
on mesothelial cells after incubation the mesothelium with ROS. The results of this study 
give evidence that the inﬂ ammatory response, i.c. PMN inﬂ ux after surgery promotes 
tumour adherence.
Chapter 5
Pancreatic tumour cell adhesion after incubation of the mesothelium with ROS has been 
studied in this chapter. Panc-1 tumour cell adhesion increases after pre-incubating the 
mesothelium with the X/XO generating system. This stimulatory effect of ROS could be 
inhibited almost completely with the anti-oxidant enzymes superoxide dismutase (SOD) 
and catalase. The enhancement of expression of adhesion molecules ICAM-1, VCAM-1 
and CD44 on mesothelial cells was suppressed by adding SOD and catalase to the 
X/XO generating system. These ﬁ ndings may be suggestive for using anti-oxidants as a 
treatment modality to inactivate the mesothelium after surgical trauma and in that way 
prevent tumour recurrence.
Chapter 6
Surgical handling of the peritoneum induces an inﬂ ammatory reaction during which 
a cocktail of active mediators are produced. In this study the inﬂ uence of systemically 
produced factors on tumour cell adhesion was investigated. Serum samples were ob-
tained during surgery and the mesothelium was incubated with these samples overnight. 
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Hereafter the adhesion of Caco-2 colon carcinoma cells was studied. No statistically 
signiﬁ cant changes in adhesion were observed after incubation the mesothelium with the 
different serum samples taken a day before surgery, at the start of the surgical procedure 
and 2, 4, 8, 12, 24 and 48 hours after surgery. Although this is a very simpliﬁ ed model, 
we might conclude that local tumour recurrence is mainly inﬂ uenced by locally produced 
mediators.
Chapter 7
The presence of foreign material in the abdominal cavity may aggravate the peritoneal 
lining leading to an inﬂ ammatory reaction of the peritoneum. This defensive mechanism 
can provoke adhesion formation and, according to previous studies done in vivo, also 
enhanced tumour recurrence. 
The inﬂ uence of four different type of gloves, powdered, non powdered and non-latex, 
on tumour cell adhesion in vitro was analysed. The non-powdered and/or non-latex 
gloves are not inﬂ uencing tumour cell adhesion. Powdered gloves induces a signiﬁ cant 
enhancement of tumour cell adhesion.
Despite the evidence of starch induced complications, in some countries still a consider-
able number of surgeons are using starch powdered gloves. Furthermore, beside the 
usage of starch, one should abandon all substances causing enhanced trauma to the 
peritoneum from the operating room.
Chapter 8
Adhesion of tumour cells to the mesothelium can cause a discontinuity of the cell layer, 
thereby exposing the extracellular matrix (ECM). In this way tumour cells can enter the 
underlying tissue, proliferate and grow out to form a metastasis. This study investigated 
the adhesion of Caco-2 and HT 29 cells to different components of the ECM, i.c. col-
lagen type I and IV, ﬁ bronectin and laminin. The adhesion of the tumour cell lines to the 
components of the ECM was signiﬁ cantly higher than to the mesothelium. Antibodies 
against the adhesion molecules ICAM-1, VCAM-1 and the VLA-integrins were studied. 
These inhibition assays clearly display that the α2- and α6-unit play a major role in the 
adhesive interactions between different tumour cells and components of the extracel-
lular matrix, although both tumour cell lines display different adhesion patterns to the 
components of this matrix. However, caused by the complexity of the ECM and the 
heterogeneity between the tumour cells, the exact mechanism of local tumour recurrence 
has not been unravelled yet. 
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Conclusions
• IL-1β and TNF-α enhance the adhesion of colon carcinoma cells to human me-
sothelial cells in vitro. 
• The enhancement of adhesion of colon carcinoma cells to mesothelial monolay-
ers is based on a cytokine induced upregulation of adhesion molecules, i.c. 
ICAM-1, VCAM-1 and CD44.
• Caco-2 and HT-29 can beneﬁ t this upregulation of adhesion molecules, because 
they express the counterparts of ICAM-1 and VCAM-1, i.c. LFA-1 and VLA-4.
• IL-1β and TNF-α stimulate the adhesion of BxpC-3 and MiaPaCa-2 cells, both 
pancreatic cancer cell lines, to monolayers mesothelium. 
• ROS produced by PMN, enhance tumour cell adhesion to mesothelial monolay-
ers. The ROS producing system X/XO resulted in the highest enhancement of 
tumour cell adhesion. 
• The expression of ICAM-1, VCAM-1 and CD44 on mesothelial cells is enhanced 
by the ROS producing system X/XO.
• Serum produced per-operatively does not inﬂ uence the adhesion of tumour cells 
to mesothelial monolayers.
• The adhesion of tumour cells to mesothelial monolayers is signiﬁ cantly enhanced 
after incubating the monolayers with powdered gloves solutions.
• Colon carcinoma cells display a strong adhesion to components of the ECM.
• Interference with the local inﬂ ammatory response after surgery may prevent intra-
abdominal tumour recurrence.
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De incidentie van colon carcinomen (kwaadaardige tumoren van de dikke darm) neemt 
toe in de westerse wereld. In Europa wordt jaarlijks bij 400 000 patiënten dikke darm 
kanker vastgesteld en overlijden er jaarlijks 200 000 patiënten met deze vorm van 
kanker. Van alle vormen van kanker staan colon carcinomen met een incidentie van 14% 
op de derde plaats na long- en prostaatkanker. De overall 5-jaarsoverleving is ongeveer 
60-70%, indien er sprake is van lokale uitzaaiing (lokaal recidief) daalt de 5-jaarsoverle-
ving naar 35% en bij uitzaaiingen in andere organen (metastasen) naar 25%.
Kwaadaardige tumoren van de alvleesklier (pancreas) hebben een zeer slechte prog-
nose. Na chirurgische resectie zal meer dan 50% van de patiënten een metastase 
ontwikkelen. Minder dan 15% van de patiënten met een pancreas carcinoom overleeft 
het eerste jaar en de 5-jaarsoverleving is kleiner dan 5%. 
De behandeling van keuze bij colon of pancreas carcinomen is chirurgische resectie. 
Het nadeel van deze chirurgische behandeling is dat tijdens de operatie tumorcellen 
kunnen los raken door manipulatie van de primaire tumor (‘spilled tumour cells’). Deze 
tumorcellen kunnen aanhechten op het resetievlak of op een andere plaats in de buik en 
op deze manier uitgroeien tot een recidief tumor. Bij zowel colon als pancreas carcino-
men komt lokaal tumor recidief vaak voor. Daarom is kennis van het ontstaan van lokaal 
tumor recidief zeer belangrijk. Dit proces kan uitgesplitst worden in tumorcel aanhechting 
en tumor groei. Het proces van aanhechting van een tumorcel is afhankelijk van een 
groot aantal factoren. De experimenten beschreven in dit proefschrift bestuderen het 
proces van aanhechting van de tumorcel en de invloed van factoren, die postoperatief 
intra-abdominaal (in de buik) worden geproduceerd op deze aanhechting.
Experimenten
Alle organen in de buik zijn bedekt door het peritoneum (buikvlies), hetgeen is opge-
bouwd uit mesotheelcellen van slechts een cellaag dik met daaronder de extra cellulaire 
matrix (ECM), opgebouwd uit eiwitten. In voorgaande experimenten in ons laboratorium 
is aangetoond, dat er een correlatie bestaat tussen chirurgische beschadiging van het 
peritoneum en postoperatief tumor recidief. De ontstekingsreactie die na chirurgisch pe-
ritoneaal trauma ontstaat is van grote invloed op het ontstaan van lokaal tumor recidief. 
Deze voorgaande studies zijn verricht in een rattenmodel. Om het gedrag van humane 
cellen te bestuderen, is er voor de experimenten beschreven in dit proefschrift een in 
vitro model ontwikkeld waarin de interactie tussen humane mesotheel- en tumorcellen is 
bestudeerd. De term ‘in vitro’ verwijst naar de observatie van fenomenen ‘onder glas’, 
ook wel een celkweekmodel genoemd. In dit model hebben wij de invloed van ontste-
kingsmediatoren, zoals leukocyten en cytokinen op de aanhechting van tumorcellen op 
mesotheelcellen bestudeerd. 
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Mesotheelcellen werden geïsoleerd uit omentum (buikschort), verkregen tijdens een 
operatie met toestemming van de patiënt. De mesotheelcellen werden gekweekt met 
toevoeging van cytokinen, IL-1β, IL-6 en TNF-α, in het kweekmedium gedurende 12 uur. 
Hierna werden de tumorcellen bij de mesotheel cellen gevoegd en de aanhechting van 
de tumorcellen gemeten. Na incubatie van de mesotheelcellen met de cytokinen IL-1β en 
TNF-α was er een evidente toename van aanhechting van tumorcellen waarneembaar. Er 
was sprake van een verhoogde expressie van adhesiemoleculen (aanhechtingsmolecu-
len) op de mesotheelcellen na incubatie van de mesotheelcellen met cytokinen, hetgeen 
de toename van aanhechting van tumorcellen op de mesotheelcellen verklaart. Dit fe-
nomeen is waargenomen bij zowel colon carcinoom cellijnen als pancreas carcinoom 
cellijnen. 
Tijdens en na een chirurgische ingreep is er sprake van een toename van witte bloedcel-
len intra-abdominaal, ook wel polymorphe neutrophiele leukocyten (PMN) genoemd. 
Deze PMN zorgen voor een uitstoot van zuurstofradicalen. Deze zuurstofradicalen dra-
gen bij aan de vernietiging van ongewenste organismen intra-abdominaal en brengen 
omliggende cellen in een verhoogde staat van activiteit. De aanhechting van tumorcellen 
was verhoogd, nadat de mesotheelcellen samen met de PMN werden gekweekt. Deze 
zuurstofradicaal productie werd tevens nagebootst door de mesotheelcellen te kweken 
met een zuurstofradicaal productie systeem, xanthine/xanthine oxidase (X/XO). Na 
incubatie van de mesotheelcellen met dit systeem was de aanhechting van tumorcel-
len signiﬁ cant verhoogd. Er werd ook een verhoogde expressie van adhesiemoleculen 
waargenomen na incubatie van de mesotheelcellen met zuurstofradicalen. 
Een daaropvolgende vraag was of het mechanisme van lokale aanhechting alleen 
verklaard kan worden door een toename van lokaal geproduceerde factoren, of dat 
factoren in bloedcirculatie ook een invloed hebben op de aanhechting. Daartoe werden 
bloed samples van patiënten verzameld voor, tijdens en na de operatie en uit deze 
samples werd het serum geëxtraheerd. Mesotheelcellen van dezelfde patiënt werden 
geincubeerd met deze samples waarna de aanhechting werd bestudeerd. Er werd geen 
toename gezien in aanhechting van tumorcellen na pre-incubatie van de mesotheelcellen 
met de serum samples. 
Uit voorgaande experimenten weten wij dat poeder, hetgeen gebruikt wordt in de ‘chi-
rurgische’ handschoenindustrie, zeer nadeling is voor tumor recidief. In ons humane 
model hebben we de invloed van 4 soorten handschoenextracties (i.c extracties van 
handschoenen met poeder en zonder poeder) op tumorcel aanhechting bestudeerd. Het 
extract van de handschoenen met poeder zorgde voor een signiﬁ cante toename van 
aanhechting van tumor cellen op mesotheelcellen.
Naast de aanhechting van tumorcellen op mesotheelcellen is ook de aanhechting van tu-
morcellen op de extra cellulaire matrix (ECM, de laag waar mesotheelcellen op rusten en 
opgebouwd is uit eiwitten) van belang in tumor metastasering. De aanhechting van tumor 
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werd bestudeerd op verschillende substanties van de ECM. De colon carcinoom cellijnen 
hechten zeer sterk aan de verschillende componenten van de ECM en de aanhechting 
kan worden geremd door de tumorcellen te incuberen met speciﬁ eke antilichamen tegen 
bepaalde adhesiemoleculen.
Toekomst
Concluderend kan gesteld worden dat de ontstekingsfactoren, die geproduceerd worden 
tijdens en na een operatie, invloed hebben op de aanhechting van tumorcellen in dit 
humane in vitro model. Toch blijft chirurgie de therapie van keuze bij colon en pancreas 
carcinomen, maar het is belangrijk om tijdens de operatie de chirurgische schade zoveel 
mogelijk te beperken. Tevens is interferentie met de ontstekingsmediatoren mogelijk ook 
een optie om het lokaal tumor recidief te voorkomen. De genezing komt tot stand, door-
dat er verschillende ontstekingsmechanismen werkzaam zijn tijdens en na een operatie. 
Al deze pathways stop zetten is geen optie, omdat dan het genezingsproces wordt stil 
gezet en de patiënt na de operatie in een shock terecht kan komen. Wellicht is de ontwik-
keling van een multifunctioneel ‘elixer’ een alternatief. Dit elixer kan postoperatief in de 
buik achter gelaten worden om bepaalde ontstekingsfactoren weg te vangen en tevens 
een barrière vormen tegen de aanhechting van ‘spilled tumour cells’.
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